Case number 1:24-md-03103
In Re: Aflibercept Patent Litigation > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 1, 2025 | 689 | CERTIFICATE OF SERVICE by Amgen Inc. for Amgen's Objections and Responses to Regeneron's First Set of Interrogatories (Nos. 1-3). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 12/01/2025) (2) |
| Nov 24, 2025 | 687 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Priority Requests for the Production of Documents and Things by Amgen. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 11/24/2025) (1) |
| Nov 24, 2025 | 688 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. Regeneron's Priority Requests for the Production of Documents and Things to Samsung Bioepis Co., Ltd.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 11/24/2025) (1) |
| Nov 21, 2025 | 683 | CERTIFICATE OF SERVICE by Amgen Inc., Amgen, Inc. Amgen's Objections and Responses to Regeneron's Fourth Requests for Production of Documents to Amgen (Nos. 28-125). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 11/21/2025) (2) |
| Nov 21, 2025 | 684 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen, Inc. Amgen's Supplemental Responses and Objections to Regeneron's First Set of Requests for Production (Nos. 1-24). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 11/21/2025) (2) |
| Nov 21, 2025 | 685 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen, Inc. Amgen's Supplemental Responses and Objections to Regeneron's Second Set of Requests for Production (Nos. 25-26). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 11/21/2025) (2) |
| Nov 21, 2025 | 686 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen, Inc. Amgen's Supplemental Responses and Objections to Regeneron's Third Set of Requests for Production (No. 27). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 11/21/2025) (2) |
| Nov 17, 2025 | 681 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron Pharmaceuticals, Inc.'s Objections and Responses to Defendant Amgen Inc.'s First Set of Interrogatories (Nos. 1-7). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 11/17/2025) (1) |
| Nov 17, 2025 | 682 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron Pharmaceuticals, Inc.'s Objections and Responses to Amgen Inc.'s Second Set of Requests for the Production of Documents and Things (Nos. 42 - 310). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 11/17/2025) (1) |
| Nov 12, 2025 | 680 | MOTION TO STRIKE CERTAIN AFFIRMATIVE DEFENSES AND DISMISS CERTAIN COUNTERCLAIMS by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment REGENERON'S MEMORANDUM IN SUPPORT OF MOTION TO STRIKE CERTAIN AFFIRMATIVE DEFENSES AND DISMISS CERTAIN COUNTERCLAIMS, # 2 Attachment DECLARATION OF ARTHUR J. ARGALL III IN SUPPORT OF REGENERON PHARMACEUTICALS, INC.'S MOTION TO STRIKE CERTAIN AFFIRMATIVE DEFENSES AND DISMISS CERTAIN COUNTERCLAIMS, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 11/12/2025) (0) |
| Oct 30, 2025 | 679 | Request to Discontinue E-mail Notification. (Griffith, M.) (Entered: 10/30/2025) (0) |
| Oct 29, 2025 | 678 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's First Set of Interrogatories to Amgen. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 10/29/2025) (1) |
| Oct 22, 2025 | 675 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL (ECF NOS. 671 , 672 ). Signed by Chief District Judge Thomas S. Kleeh on 10/22/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 10/22/2025) (1) |
| Oct 21, 2025 | 673 | STIPULATION AND ORDER DISMISSING ALL CLAIMS AND COUNTERCLAIMS, VACATING PRELIMINARY INJUNCTION PREVIOUSLY ISSUED BY THE COURT, AND RELEASING PRELIMINARY INJUNCTION BOND. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK (snc) (Entered: 10/21/2025) (5) |
| Oct 21, 2025 | 674 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Fourth Requests for Production of Documents to Amgen. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 10/21/2025) (1) |
| Oct 20, 2025 | 669 | AMENDED MEMORANDUM OPINION AND ORDER DENYING REGENERON'S MOTION TO STRIKE SAMSUNG BIOEPIS'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSE AND TO DISMISS ITS INEQUITABLE CONDUCT COUNTERCLAIM (ECF NO. 472 ). Signed by Chief District Judge Thomas S. Kleeh on 10/20/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 10/20/2025) (4) |
| Oct 20, 2025 | 670 | STIPULATION AND [PROPOSED] ORDER DISMISSING ALL CLAIMS AND COUNTERCLAIMS, VACATING PRELIMINARY INJUNCTION PREVIOUSLY ISSUED BY THE COURT, AND RELEASING PRELIMINARY INJUNCTION BOND by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Ruby, Steven) (Entered: 10/20/2025) (5) |
| Oct 20, 2025 | 671 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Placeholder)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM(Pogue, David) (Entered: 10/20/2025) (0) |
| Oct 20, 2025 | 672 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Placeholder)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 10/20/2025) (0) |
| Oct 15, 2025 | 667 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen Inc., Amgen, Inc. Amgen, Inc.'s First Set of Interrogatories to Regeneron Pharmaceuticals, Inc. (Nos. 1-7). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 10/15/2025) (2) |
| Oct 15, 2025 | 668 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen, Inc. Defendant Amgen, Inc.'s Second Set of Requests for Production of Documents and Things to Regeneron Pharmaceuticals, Inc. (Nos. 42-310). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 10/15/2025) (2) |
| Oct 3, 2025 | 666 | Corrected ANSWER to Complaint by Amgen Inc., Amgen Inc., Amgen, Inc..Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 10/03/2025) (30) |
| Sep 29, 2025 | 660 | STIPULATION AND [PROPOSED] ORDER DISMISSING ALL CLAIMS AND COUNTERCLAIMS, VACATING PRELIMINARY INJUNCTION PREVIOUSLY ISSUED BY THE COURT, AND RELEASING PRELIMINARY INJUNCTION BOND by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 09/29/2025) (6) |
| Sep 29, 2025 | 661 | STIPULATION AND ORDER DISMISSING ALL CLAIMS AND COUNTERCLAIMS, VACATING PRELIMINARY INJUNCTION PREVIOUSLY ISSUED BY THE COURT, AND RELEASING PRELIMINARY INJUNCTION BOND. All pending motions in Case No. 1:23-cv-97 are hereby TERMINATED and the Clerk isDIRECTED to STRIKE Case No. 1:23-cv-97 from the Court's active docket and to STRIKE Formycon as a party in Case No. 1:24-md-03103. Signed by Chief District Judge Thomas S. Kleeh on 09/29/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Main Document 661 replaced on 10/6/2025) (snc). (Entered: 09/29/2025) (4) |
| Sep 29, 2025 | 662 | ORDER CANCELING HEARING. In light of the parties stipulation to dismiss all claims (ECF No. 660 ), the hearing is hereby CANCELED. Signed by Chief District Judge Thomas S. Kleeh on 09/29/2025. (snc) (Entered: 09/29/2025) (1) |
| Sep 29, 2025 | 663 | SCHEDULING ORDER: Discovery due by 11/4/2026. Markman Hearing set for 11/23/2026 09:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh. Motions due by 2/17/2027. Signed by Chief District Judge Thomas S. Kleeh on 09/29/2025. Associated Cases: 1:24-md-03103-TSK-JPM et al.(snc) (Entered: 09/29/2025) (2) |
| Sep 29, 2025 | 664 | ORDER DENYING CERTAIN MOTIONS AS MOOT (ECF NOS. 334 , 478 , 490 ). Signed by Chief District Judge Thomas S. Kleeh on 09/29/2025. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 09/29/2025) (1) |
| Sep 29, 2025 | 665 | STIPULATION AND [PROPOSED] ORDER FURTHER EXTENDING DEADLINE TO ANSWER COUNTERCLAIMS by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 09/29/2025) (5) |
| Sep 26, 2025 | 659 | STIPULATION AND PROPOSED BRIEFING SCHEDULE by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 09/26/2025) (5) |
| Sep 24, 2025 | 658 | ORDER GRANTING STIPULATION EXTENDING DEADLINE TO ANSWER COUNTERCLAIMS (ECF NO. 657 ). Regeneron's answer deadline is EXTENDED to October 6, 2025. Signed by Chief District Judge Thomas S. Kleeh on 09/24/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(snc) (Entered: 09/24/2025) (1) |
| Sep 22, 2025 | 656 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regenerons Objections and Responses to Defendant Celltrion Inc.s Third Set of Requests for the Production of Documents and Things (Nos. 35-48). Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 09/22/2025) (1) |
| Sep 22, 2025 | 657 | STIPULATION EXTENDING DEADLINE TO ANSWER COUNTERCLAIMS by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 09/22/2025) (4) |
| Sep 19, 2025 | 655 | CERTIFICATE OF SERVICE by Celltrion, Inc., Celltrion, Inc. for Celltrion Inc.s Objections And Responses to Regenerons Third Requests For Production of Documents to Celltrion, Inc. (Nos. 39-59). Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Gottlieb, Max) (Entered: 09/19/2025) (1) |
| Sep 17, 2025 | 654 | ORDER granting 652 Motion for Leave to Appear Pro Hac Vice for Edward Anthony Figg in case 1:24-md-03103-TSK-JPM and granting (98) Motion for Leave to Appear in case 1:25-cv-00074-TSK. Signed by Chief District Judge Thomas S. Kleeh on 9/17/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK (jb) (Entered: 09/17/2025) (1) |
| Sep 16, 2025 | 651 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Third Requests for Production of Documents to Celltrion Inc. (Nos. 39-59). Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 09/16/2025) (1) |
| Sep 16, 2025 | 652 | MOTION for Leave to Appear Pro Hac Vice by Edward A. Figg by Amgen Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 09/16/2025) (0) |
| Sep 16, 2025 | 653 | Pro Hac Vice Filing fee: $ 200.00, receipt number 100004075. (For Edward Figg) Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK (snc) (Entered: 09/16/2025) (0) |
| Sep 15, 2025 | 646 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL (ECF NOS. 629 , 643 ). Signed by Chief District Judge Thomas S. Kleeh on 09/15/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 09/15/2025) (1) |
| Sep 15, 2025 | 649 | ORDER APPROVING APPLICATIONS TO APPEAR PRO HAC VICE. (John R. Labbe, Kevin M. Flowers, Thomas R. Burns, Brett A. Postal, Jennifer P. Nock, Joseph A. Hynds) Signed by Chief District Judge Thomas S. Kleeh on 09/15/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(snc) (Entered: 09/15/2025) (1) |
| Sep 15, 2025 | 650 | STIPULATION and Briefing Schedule by Celltrion, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Gottlieb, Max) (Entered: 09/15/2025) (5) |
| Sep 12, 2025 | 635 | MOTION for Leave to Appear Pro Hac Vice by John R. Labbe by Amgen Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 09/12/2025) (0) |
| Sep 12, 2025 | 636 | MOTION for Leave to Appear Pro Hac Vice by Kevin M. Flowers by Amgen Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 09/12/2025) (0) |
| Sep 12, 2025 | 637 | MOTION for Leave to Appear Pro Hac Vice by Thomas R. Burns by Amgen Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 09/12/2025) (0) |
| Sep 12, 2025 | 638 | MOTION for Leave to Appear Pro Hac Vice by Brett A. Postal by Amgen Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 09/12/2025) (0) |
| Sep 12, 2025 | 639 | MOTION for Leave to Appear Pro Hac Vice by Jennifer P. Nock by Amgen Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 09/12/2025) (0) |
| Sep 12, 2025 | 640 | MOTION for Leave to Appear Pro Hac Vice by Joseph A. Hynds by Amgen Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 09/12/2025) (0) |
| Sep 12, 2025 | 641 | Pro Hac Vice filing fee for John R. Labbe, Kevin M. Flowers, Thomas R. Burns, Brett A. Postal, Jennifer P. Nock and Joseph A. Hynds in the amount of $1,200.00 has been paid. Receipt Number: 100004068. Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK (jb) (Entered: 09/12/2025) (0) |
| Sep 12, 2025 | 642 | Corporate Disclosure Statement by Amgen Inc., Amgen Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(Labbe, John) (Entered: 09/12/2025) (2) |
| Sep 12, 2025 | 643 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Placeholder)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 09/12/2025) (0) |
| Sep 12, 2025 | 644 | ANSWER to Complaint by Amgen, Inc..Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(cmd) Modified to correct file date on 9/15/2025 (snc). (Entered: 09/15/2025) (30) |
| Sep 12, 2025 | 645 | COUNTERCLAIM against Regeneron Pharmaceuticals, Inc., filed by Amgen, Inc.(cmd) Modified to correct file date on 9/15/2025 (snc). (Entered: 09/15/2025) (30) |
| Sep 10, 2025 | 633 | ORDER GRANTING FORMYCON AG'S REQUEST FOR HEARING ON ITS MOTION TO DISSOLVE PRELIMINARY INJUNCTION (ECF NO. 581 ). Formycon AG's request for hearing is GRANTED. The hearing on Formycon AG's 521 Motion to Dissolve Preliminary Injunction is SCHEDULED for SEPTEMBER 29, 2025, at 10:00 a.m., at the Clarksburg, West Virginia, point of holding court. Signed by Chief District Judge Thomas S. Kleeh on 09/10/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 09/10/2025) (1) |
| Sep 10, 2025 | 634 | NOTICE by Formycon AG of Withdrawal of Counsel of PHV Shaun M. VanHorn Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 09/10/2025) (3) |
| Sep 9, 2025 | 631 | STIPULATION AND [PROPOSED] ORDER DISMISSING ALL CLAIMS AND COUNTERCLAIMS by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Ruby, Steven) (Entered: 09/09/2025) (5) |
| Sep 9, 2025 | 632 | STIPULATION AND ORDER DISMISSING ALL CLAIMS AND COUNTERCLAIMS. All pending motions in Case No. 1:24-cv-85 are hereby TERMINATED and the Clerk is DIRECTED to STRIKE Case No. 1:24-cv-85 from the Court's active docket and to STRIKE Sandoz Inc. as a party in Case No. 1:24-md-03103. Signed by Chief District Judge Thomas S. Kleeh on 09/09/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 09/09/2025) (4) |
| Sep 8, 2025 | 630 | MEMORANDUM OPINION AND ORDER DENYING REGENERON'S MOTION TO STRIKE SAMSUNG BIOEPIS'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSE AND TO DISMISS ITS INEQUITABLE CONDUCT COUNTERCLAIM (ECF NO. 472 ). Signed by Chief District Judge Thomas S. Kleeh on 09/08/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) (Entered: 09/08/2025) (4) |
| Sep 5, 2025 | 629 | MOTION for Leave to File Under Seal its Response in Opposition to Regeneron Pharmaceuticals, Inc.'s Motion to Strike Portions of Formycon's Reply Brief or, in the Alternative, for Sur-Reply by Formycon AG. (Attachments: # 1 Exhibit 1 - Placeholder, # 2 Memorandum in Support of Motion for leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 09/05/2025) (0) |
| Sep 3, 2025 | 627 | ORDER granting 616 Motion for Leave to Appear Pro Hac Vice (Jesse M. WEiss) in case 1:24-md-03103-TSK-JPM; granting (288) Motion for Leave to Appear Pro Hac Vice in case 1:24-cv-00039-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/03/2025) (1) |
| Sep 3, 2025 | 628 | ORDER granting 617 Motion for Leave to Appear Pro Hac Vice (Timothy G. Cameron) in case 1:24-md-03103-TSK-JPM; granting (289) Motion for Leave to Appear Pro Hac Vice in case 1:24-cv-00039-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/03/2025) (1) |
| Sep 2, 2025 | 625 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Howard L. Levine, Ph.D. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 09/02/2025) (1) |
| Aug 29, 2025 | 624 | ***SEALED*** ORDER. Signed by Magistrate Judge James P. Mazzone on 8/29/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (jb) (Copy to counsel of record) (Entered: 08/29/2025) (0) |
| Aug 28, 2025 | 619 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 611 ). Signed by Chief District Judge Thomas S. Kleeh on 08/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/28/2025) (1) |
| Aug 28, 2025 | 621 | ORDER DENYING CERTAIN MOTIONS AS MOOT (ECF NOS. 181 , 299 ). Signed by Chief District Judge Thomas S. Kleeh on 08/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/28/2025) (1) |
| Aug 28, 2025 | 622 | ORDER DENYING AS MOOT PLAINTIFF'S MOTION TO STRIKE DEFENDANT'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSES AND TO DISMISS DEFENDANT'S INEQUITABLE CONDUCT COUNTERCLAIMS (ECF NO. 434 ). Signed by Chief District Judge Thomas S. Kleeh on 08/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 08/28/2025) (1) |
| Aug 27, 2025 | 616 | MOTION for Leave to Appear Pro Hac Vice by Jesse M. Weiss by Amgen, Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 08/27/2025) (0) |
| Aug 27, 2025 | 617 | MOTION for Leave to Appear Pro Hac Vice by Timothy G. Cameron by Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 08/27/2025) (0) |
| Aug 27, 2025 | 618 | Pro Hac Vice Filing fee: $ 400.00, receipt number 100004061 (for J. Weiss and T. Cameron) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/27/2025) (0) |
| Aug 26, 2025 | 613 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Mohan Rao, Ph.D.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 08/26/2025) (1) |
| Aug 26, 2025 | 614 | NOTICE of Appearance by L. Elizabeth King on behalf of Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(King, L. Elizabeth) (Entered: 08/26/2025) (2) |
| Aug 26, 2025 | 615 | Other Document REGENERON'S RESPONSE TO FORMYCON'S EMERGENCY MOTION FOR PROTECTIVE ORDER filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 08/26/2025) (7) |
| Aug 22, 2025 | 610 | ORDER OF REFERRAL (ECF NOS. 591 , 597 ). Signed by Chief District Judge Thomas S. Kleeh on 08/22/2025. (Copy to Judge Mazzone) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/22/2025) (1) |
| Aug 22, 2025 | 611 | MOTION FOR LEAVE TO FILE UNDER SEAL by Regeneron Pharmaceuticals, Inc. (Attachments: # 1 Exhibit Placeholder) (Document was only filed in the Member Case) (snc) (Entered: 08/26/2025) (0) |
| Aug 22, 2025 | 612 | MEMORANDUM OF LAW IN SUPPORT OF MOTION FOR LEAVE TO FILE UNDER SEAL by Regeneron Pharmaceuticals, Inc. re 611 MOTION for Leave to File. (Memorandum was only filed in the Member Case) (snc) (Entered: 08/26/2025) (6) |
| Aug 21, 2025 | 608 | ORDER GRANTING MOTION TO STRIKE (ECF NO. 561 ). Signed by Chief District Judge Thomas S. Kleeh on 08/21/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 08/21/2025) (1) |
| Aug 21, 2025 | 609 | ORDER DENYING AS MOOT MOTION FOR LEAVE TO FILE A SUR-REPLY (ECF NO. 558 ). Signed by Chief District Judge Thomas S. Kleeh on 08/21/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/21/2025) (1) |
| Aug 20, 2025 | 607 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 556 ). Signed by Chief District Judge Thomas S. Kleeh on 08/20/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/20/2025) (1) |
| Aug 19, 2025 | 602 | ORDER GRANTING MOTION TO RESCHEDULE MOTION HEARING (ECF NO. 578 ). The hearing is RESCHEDULED to September 29, 2025, at 10:00 a.m., at the Elkins, West Virginia, point of holding court. Signed by Chief District Judge Thomas S. Kleeh on 08/19/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(snc) (Entered: 08/19/2025) (1) |
| Aug 19, 2025 | 603 | AMENDED ORDER GRANTING MOTION TO RESCHEDULE MOTION HEARING (ECF NO. 578 ). The hearing is RESCHEDULED to September 29, 2025, at 10:00 a.m., at the Clarksburg, West Virginia, point of holding court. Signed by Chief District Judge Thomas S. Kleeh on 08/19/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 08/19/2025) (1) |
| Aug 19, 2025 | 604 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 598 ). Signed by Chief District Judge Thomas S. Kleeh on 08/19/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 08/19/2025) (1) |
| Aug 19, 2025 | 606 | ORDER GRANTING JOINT MOTION TO PERMIT PARTIES' LOCAL COUNSEL TO ATTEND DEPOSITIONS BY TELEPHONE OR OTHER ELECTRONIC MEANS (ECF NO. 594 ). Signed by Chief District Judge Thomas S. Kleeh on 08/19/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 08/19/2025) (1) |
| Aug 15, 2025 | 598 | MOTION for Leave to File Under Seal by Sandoz Inc.. (Attachments: # 1 Attachment Memorandum of Law in Support of Sandoz's Motion for Leave to File Under Seal, # 2 Proposed Order Order Granting Motion to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 08/15/2025) (0) |
| Aug 15, 2025 | 599 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL (ECF NOS. 584 , 587 , 590 , 596 ). Signed by Chief District Judge Thomas S. Kleeh on 08/15/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/15/2025) (1) |
| Aug 15, 2025 | 600 | MOTION for Leave to File Under Seal its Response in Opposition to Regeneron Pharmaceuticals, Inc.'s Motion to Hold In Abeyance Formycon's Emergency Motion for Protective Order by Formycon AG. (Attachments: # 1 Attachment Defendant Formycon AG's Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 08/15/2025) (0) |
| Aug 15, 2025 | 601 | CERTIFICATE OF SERVICE by Sandoz Inc. . Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 08/15/2025) (2) |
| Aug 13, 2025 | 592 | MOTION for Leave to Appear Pro Hac Vice Application for Admission Pro Hac Vice by Sandoz Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 08/13/2025) (3) |
| Aug 13, 2025 | 593 | Pro Hac Vice Filing fee: $ 200.00, receipt number 500003862 (For William M. Jay) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(snc) (Entered: 08/13/2025) (0) |
| Aug 13, 2025 | 594 | Joint MOTION Joint Motion to Permit Parties' Local Counsel to Attend Depositions by Telephone or Other Electronic Means by Sandoz Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 08/13/2025) (6) |
| Aug 13, 2025 | 595 | ORDER granting 592 Motion for Leave to Appear Pro Hac Vice (William M. Jay). Signed by Chief District Judge Thomas S Kleeh on 08/13/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 08/13/2025) (1) |
| Aug 13, 2025 | 596 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 08/13/2025) (0) |
| Aug 12, 2025 | 590 | MOTION for Leave to File Under Seal its Emergency Motion for Protective Order and Memorandum in Support by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 08/12/2025) (0) |
| Aug 7, 2025 | 589 | STIPULATION by Amgen Inc., Amgen Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 08/07/2025) (4) |
| Aug 5, 2025 | 586 | REPLY to Response to Motion re (357 in 1:23-cv-00097-TSK-JPM) MOTION for Leave to File UNDER SEAL, (355 in 1:23-cv-00097-TSK-JPM) MOTION Formycon AG's Reply in Support of Its Request for Hearing on Its Motion to Dissolve the Preliminary Injunction filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 08/05/2025) (4) |
| Aug 5, 2025 | 587 | MOTION for Leave to File Under Seal its Supplemental Exhibit A to Its Reply in Support of Its Request for Hearing on Its Motion to Dissolve the Preliminary Inunction by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 08/05/2025) (0) |
| Aug 1, 2025 | 584 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 08/01/2025) (0) |
| Jul 31, 2025 | 583 | MEMBER CASE OPENED: Case Transferred into the Northern District of West Virginia: District of California Central, 2:25-cv-05499, REGENERON PHARMACEUTICALS, INC. v. AMGEN INC. as NDWV case 1:25-cv-74 pursuant to 577 CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) and filed the 24 Pretrial Order #1: INITIAL SCHEDULING CONFERENCE. (snc) (Entered: 07/31/2025) (0) |
| Jul 28, 2025 | 582 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 579 ). Signed by Chief District Judge Thomas S. Kleeh on 07/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/28/2025) (1) |
| Jul 25, 2025 | 579 | MOTION for Leave to File Under Seal its Reply Memorandum in Support of its Motion to Dissolve the Preliminary Injunction by Formycon AG. (Attachments: # 1 Defendant Formycon AG's Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/25/2025) (0) |
| Jul 25, 2025 | 581 | Request for Hearing on its Motion to Dissolve the Preliminary Injunction filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) Modified to make pending motion on 7/28/2025 (dk). (Entered: 07/25/2025) (3) |
| Jul 24, 2025 | 578 | Joint MOTION to Reschedule Preliminary Injunction Hearing by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 07/24/2025) (4) |
| Jul 17, 2025 | 577 | JPML CONDITIONAL TRANSFER ORDER FINALIZED (CTO-2) - 1 action(s) re: pldg. (1 in CAC/2:25-cv-05499, 50 in MDL No. 3103) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 7/17/2025. Associated Cases: MDL No. 3103, CAC/2:25-cv-05499. (snc) (Entered: 07/17/2025) (2) |
| Jul 16, 2025 | 574 | NOTICE by Sandoz Inc. Defendants' Notice of Deposition of Dr. Sean Sheridan Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 07/16/2025) (3) |
| Jul 16, 2025 | 575 | NOTICE by Sandoz Inc. Defendants' Notice of Deposition of Kevin Clark Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 07/16/2025) (3) |
| Jul 16, 2025 | 576 | NOTICE by Sandoz Inc. Defendants' Notice of Deposition of Dr. Bernhardt Trout Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 07/16/2025) (3) |
| Jul 15, 2025 | 573 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 570 ). Signed by Chief District Judge Thomas S. Kleeh on 07/15/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 07/15/2025) (1) |
| Jul 14, 2025 | 572 | CERTIFICATE OF SERVICE by Formycon AG certifying service of Formycon's Notice of Deposition of Kevin Clark. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/14/2025) (1) |
| Jul 11, 2025 | 569 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL AND TO SUBSTITUTE EXHIBITS. The following motions to seal are GRANTED: ECF Nos. 562 , 566 . Signed by Chief District Judge Thomas S. Kleeh on 07/11/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 07/11/2025) (1) |
| Jul 11, 2025 | 570 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 07/11/2025) (0) |
| Jul 9, 2025 | 568 | CERTIFICATE OF SERVICE by Formycon AG certifying service of the Notice of Deposition of Dr. Sean Sheridan. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/09/2025) (1) |
| Jul 2, 2025 | 566 | Emergency MOTION for Leave to File TO FILE CORRECTED VERSIONS OF EXHIBITS 68-69, 109, 165-166, AND 169-172 TO SUPPLEMENTAL SHERIDAN DECLARATION UNDER SEAL AND TO SUBSTITUTE EXHIBITS 1-5 TO SUPPLEMENTAL SHERIDAN DECLARATION UNDER SEAL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 07/02/2025) (5) |
| Jul 1, 2025 | 565 | CERTIFICATE OF SERVICE by Sandoz Inc. documents required by D.I. 69. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 07/01/2025) (1) |
| Jun 27, 2025 | 559 | NOTICE by Sandoz Inc. Rule 30(b)(6) Deposition and Subpoena to Non-Party Amgen Inc. (Wakefield, Jeffrey) (Entered: 06/27/2025) (30) |
| Jun 27, 2025 | 560 | NOTICE by Sandoz Inc. Rule 30(b)(6) Deposition and Subpoena to Non-Party Biocon Biologics Inc. (Wakefield, Jeffrey) (Entered: 06/27/2025) (30) |
| Jun 27, 2025 | 561 | MOTION to Strike CM/ECF DOC 70 Notice of Rule 30(b)(6) Deposition and Subpoena to Non- Party Biocon Biologics Inc. by Sandoz Inc.. (Wakefield, Jeffrey) (Entered: 06/27/2025) (2) |
| Jun 27, 2025 | 562 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/27/2025) (0) |
| Jun 26, 2025 | 550 | MOTION for Leave to File Under Seal its Response in Opposition to Plaintiff Regeneron Pharmaceuticals, Inc.'s Renewed Emergency Motion to Compel and Amend Briefing Schedule by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 06/26/2025) (0) |
| Jun 26, 2025 | 552 | MOTION for Leave to File REPLY AND TO FILE UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/26/2025) (0) |
| Jun 26, 2025 | 554 | ORDER GRANTING MOTION 550 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 06/26/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/26/2025) (1) |
| Jun 26, 2025 | 555 | ORORDER GRANTING MOTION 552 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 06/26/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/26/2025) (1) |
| Jun 26, 2025 | 556 | MOTION for Leave to File Under Seal its Motion for Leave to File a Sur-Reply in Opposition to Regeneron Pharmaceuticals, Inc.'s Rely in Support of Its Renewed Emergency Motion to Compel and Amend Briefing Schedule by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 06/26/2025) (0) |
| Jun 26, 2025 | 557 | ***SEALED*** ORDER. Signed by Magistrate Judge James P. Mazzone on 6/26/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (jb) (Copy to counsel of record) (Entered: 06/26/2025) (0) |
| Jun 25, 2025 | 546 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 544 ). Signed by Chief District Judge Thomas S. Kleeh on 06/25/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 06/25/2025) (1) |
| Jun 25, 2025 | 547 | ORDER REFERRING MOTION TO THE MAGISTRATE JUDGE (ECF NO. 545 ). Signed by Chief District Judge Thomas S. Kleeh on 06/25/2025. (Copy to MJ Mazzone) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/25/2025) (1) |
| Jun 25, 2025 | 548 | ORDER DIRECTING RESPONSE. Defendant is DIRECTED to file a response brief on or before June 26, 2025, at 12:00pm. Signed by Magistrate Judge James P. Mazzone on 06/25/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/25/2025) (1) |
| Jun 25, 2025 | 549 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Helmut Plutat. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/25/2025) (1) |
| Jun 24, 2025 | 544 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/24/2025) (0) |
| Jun 23, 2025 | 543 | ***SEALED***STIPULATION AND BRIEFING SCHEDULE. Signed by Chief District Judge Thomas S. Kleeh on 06/23/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 06/23/2025) (0) |
| Jun 20, 2025 | 540 | ORDER GRANTING MOTION 538 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 06/20/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/20/2025) (1) |
| Jun 20, 2025 | 541 | ***SEALED***SEALED ORDER DENYING REGENERON PHARMACEUTICALS, INC.'S EMERGENCY MOTION TO COMPEL 530 . Signed by Magistrate Judge James P. Mazzone on 06/20/2025. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | 542 | CERTIFICATE OF SERVICE by Sandoz Inc. Defendant Sandoz, Inc.'s Responses and Objections to Regeneron's First Requests for Production (Nos. 1-14). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 06/20/2025) (1) |
| Jun 19, 2025 | 537 | Other Document PARTIAL WITHDRAWAL OF MOTION TO COMPEL AND AMEND BRIEFING SCHEDULE, AS PARTIALLY MOOT filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/19/2025) (4) |
| Jun 19, 2025 | 538 | MOTION for Leave to File Under Seal by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 06/19/2025) (0) |
| Jun 18, 2025 | 531 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL [ECF NO. 529 ]. Signed by Chief District Judge Thomas S. Kleeh on 6/18/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (jb) (Entered: 06/18/2025) (1) |
| Jun 18, 2025 | 532 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Arun Sharma. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/18/2025) (1) |
| Jun 18, 2025 | 533 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 06/18/2025) (0) |
| Jun 18, 2025 | 535 | ORDER OF REFERRAL. Regeneron's Motion [ECF NO. 530 ] is REFERRED to Magistrate Judge James P. Mazzone for disposition. Signed by Chief District Judge Thomas S. Kleeh on 6/18/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (jb) (Copy to JPM) (Entered: 06/18/2025) (1) |
| Jun 18, 2025 | 536 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL [ECF NO. 533 ]. Signed by Chief District Judge Thomas S. Kleeh on 6/18/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (jb) (Entered: 06/18/2025) (1) |
| Jun 16, 2025 | 529 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/16/2025) (0) |
| Jun 12, 2025 | 528 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Responses and Objections to Defendant Sandoz Inc.'s First Set of Requests for Production (Nos. 1-64). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 06/12/2025) (1) |
| Jun 10, 2025 | 527 | CERTIFICATE OF SERVICE by Formycon AG certifying service of Formycon AG's First Supplemental Responses and Objections to Plaintiff's First Requests for Production of Documents (Nos. 1-8, 19). Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 06/10/2025) (1) |
| Jun 9, 2025 | 526 | STIPULATION AND BRIEFING SCHEDULE. Regeneron's opposition to Formycon's Motion shall be due June 27, 2025. Formycon's reply to Regeneron's opposition shall be due July 25, 2025. Signed by Chief District Judge Thomas S. Kleeh on 06/09/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/09/2025) (6) |
| Jun 6, 2025 | 525 | STIPULATION and Proposed Briefing Schedule on Defendant Formycon AG's Motion to Dissolve Preliminary Injunction by Regeneron Pharmaceuticals, Inc.. (Ruby, Steven) (Entered: 06/06/2025) (7) |
| Jun 4, 2025 | 524 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's First Requests for Production of Documents to Sandoz Inc. (Nos. 1-14). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 06/04/2025) (1) |
| May 28, 2025 | 523 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 520 ). Signed by Chief District Judge Thomas S. Kleeh on 05/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 05/28/2025) (1) |
| May 27, 2025 | 522 | NOTICE of Change of Address by M. David Griffith, Jr Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 05/27/2025) (3) |
| May 23, 2025 | 520 | MOTION for Leave to File UNDER SEAL by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 05/23/2025) (0) |
| Apr 22, 2025 | 518 | AGREED ORDER granting (870) Motion in case 1:22-cv-00061-TSK-JPM; granting 514 Motion in case 1:24-md-03103-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 04/22/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 04/22/2025) (1) |
| Apr 22, 2025 | 519 | STIPULATION AND ORDER VACATING PERMANENT INJUNCTION PREVIOUSLY ISSUED BY THE COURT IN THIS MATTER AND DISMISSING ALL CLAIMS AND COUNTERCLAIMS WITH PREJUDICE. Signed by Chief District Judge Thomas S. Kleeh on 04/22/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(snc) (Entered: 04/22/2025) (4) |
| Apr 21, 2025 | 516 | STIPULATION AND [PROPOSED] ORDER VACATING PERMANENT INJUNCTION PREVIOUSLY ISSUED BY THE COURT IN THIS MATTER AND DISMISSING ALL CLAIMS AND COUNTERCLAIMS WITH PREJUDICE by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 04/21/2025) (5) |
| Apr 21, 2025 | 517 | MANDATE of USCA FOR THE FEDERAL CIRCUIT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. (dk) (Entered: 04/21/2025) (1) |
| Apr 17, 2025 | 515 | MANDATE of USCA for the Federal Circuit as to (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. (snc) (Entered: 04/17/2025) (2) |
| Apr 15, 2025 | 514 | Joint MOTION to Lift the March 26, 2024 Order's Prosecution Bar by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 04/15/2025) (0) |
| Apr 11, 2025 | 513 | MANDATE of USCA for the Federal Circuit as to ( 269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (snc) (Entered: 04/11/2025) (1) |
| Apr 8, 2025 | 511 | CERTIFICATE OF SERVICE by BIOCON BIOLOGICS INC. (Documents produced on 3.18.25). Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 04/08/2025) (2) |
| Apr 8, 2025 | 512 | CERTIFICATE OF SERVICE by BIOCON BIOLOGICS INC. (Documents produced on 3.21.25). Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 04/08/2025) (2) |
| Apr 2, 2025 | 507 | MOTION to Withdraw as Attorney EVAN T. LEO'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Pogue, David) (Entered: 04/02/2025) (4) |
| Apr 2, 2025 | 508 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 505 ) Signed by Chief District Judge Thomas S. Kleeh on 04/02/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 04/02/2025) (1) |
| Apr 2, 2025 | 509 | ORDER. The motion for Evan T. Leo to withdraw as counsel is GRANTED (ECF No. 507 ). Evan T. Leo shall be TERMINATED as counsel of record in this matter. Signed by Chief District Judge Thomas S. Kleeh on 04/02/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(snc) (Entered: 04/02/2025) (1) |
| Apr 2, 2025 | 510 | VACATED based on Order 519 entered on 04/22/2025. STIPULATION REGARDING NOTICE. Signed by Chief District Judge Thomas S. Kleeh on 04/02/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) Modified on 4/22/2025 (snc). (Entered: 04/02/2025) (0) |
| Apr 1, 2025 | 505 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Pogue, David) (Entered: 04/01/2025) (0) |
| Mar 21, 2025 | 504 | REPLY to Response to Motion re (256 in 1:23-cv-00089-TSK-JPM, 59 in 1:24-cv-00053-TSK, 490 in 1:24-md-03103-TSK-JPM) MOTION For a Status Conference, And Notice of Partial Adoption and Joinder of Samsung Bioepis, Co., LTD's Scheduling Motion [ECF No. 478] filed by Celltrion, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Gottlieb, Max) (Entered: 03/21/2025) (6) |
| Mar 17, 2025 | 503 | ORDER. The Notice of Withdrawal of Counsel, which the Court construes as a motion, is GRANTED (ECF No. 497 ). Morgan E. Villers shall be TERMINATED as counsel of record in this matter. Signed by Chief District Judge Thomas S. Kleeh on 03/17/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(snc) (Entered: 03/17/2025) (1) |
| Mar 14, 2025 | 498 | OPINION of USCA for the Federal Circuit as to ( 344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. USCA Decision: AFFIRMED (snc) (Entered: 03/14/2025) (20) |
| Mar 14, 2025 | 499 | USCA for the Federal Circuit JUDGMENT as to ( 344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. (snc) (Entered: 03/14/2025) (1) |
| Mar 14, 2025 | 500 | REPLY to Response to Motion re (477 in 1:24-md-03103-TSK-JPM, 56 in 1:24-cv-00085-TSK) MOTION to Strike Defendant's Inequitable Conduct Affirmative Defenses and to Dismiss Defendant's Inequitable Conduct Counterclaims filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 03/14/2025) (21) |
| Mar 14, 2025 | 501 | RESPONSE to Motion re (256 in 1:23-cv-00089-TSK-JPM, 59 in 1:24-cv-00053-TSK, 490 in 1:24-md-03103-TSK-JPM) MOTION For a Status Conference, And Notice of Partial Adoption and Joinder of Samsung Bioepis, Co., LTD's Scheduling Motion [ECF No. 478] filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Ruby, Steven) (Entered: 03/14/2025) (0) |
| Mar 14, 2025 | 502 | REPLY to Response to Motion re (478 in 1:24-md-03103-TSK-JPM) MOTION filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 03/14/2025) (5) |
| Mar 13, 2025 | 497 | NOTICE by Sandoz Inc. Notice of Withdrawal of Counsel (Villers, Morgan) (Entered: 03/13/2025) (2) |
| Mar 7, 2025 | 494 | MANDATE of USCA for the Federal Circuit as to (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD., (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) (Entered: 03/07/2025) (1) |
| Mar 7, 2025 | 495 | MANDATE of USCA for the Federal Circuit as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG. (snc) (Entered: 03/07/2025) (1) |
| Mar 7, 2025 | 496 | Other Document REGENERON PHARMACEUTICALS, INC.'S RESPONSE TO DEFENDANT FORMYCON AG'S MOTION TO PARTIALLY ADOPT AND JOIN SAMSUNG BIOEPIS, CO., LTD.'S MOTION FOR ENTRY OF SCHEDULING ORDER PURSUANT TO RULE 16 OR, IN THE ALTERNATIVE, A STATUS CONFERENCE filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 03/07/2025) (0) |
| Mar 6, 2025 | 493 | ORDER. The 164 motion is DENIED WITHOUT PREJUDICE. Associated cases: (796) in case 1:22-cv-00061-TSK-JPM; (186) in case 1:23-cv-00089-TSK-JPM; (239) in case 1:23-cv-00094-TSK-JPM; (236) in case 1:23-cv-00097-TSK-JPM; (221) in case 1:23-cv-00106-TSK-JPM; (164) in case 1:24-md-03103-TSK-JPM; (184) in case 1:24-cv-00039-TSK-JPM; (17) in case 1:24-cv-00053-TSK; in case 1:24-cv-00085-TSK. Signed by Chief District Judge Thomas S Kleeh on 3/6/2025. (dk) (Entered: 03/06/2025) (1) |
| Mar 5, 2025 | 491 | OPINION OF USCA FOR THE FEDERAL CIRCUIT as to (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA Decision: AFFIRMED (dk) (Entered: 03/05/2025) (10) |
| Mar 5, 2025 | 492 | JUDGMENT OF THE USCA FOR THE FEDERAL CIRCUIT as to (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (dk) (Entered: 03/05/2025) (1) |
| Feb 28, 2025 | 488 | ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF NO. 486 ). Attorney John D. Pizzo terminated. in cases 1:24-md-03103-TSK-JPM and 1:22-cv-00061-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 02/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 02/28/2025) (1) |
| Feb 28, 2025 | 489 | RESPONSE in Opposition re (477 in 1:24-md-03103-TSK-JPM, 56 in 1:24-cv-00085-TSK) MOTION to Strike Defendant's Inequitable Conduct Affirmative Defenses and to Dismiss Defendant's Inequitable Conduct Counterclaims DEFENDANT SANDOZ INC.S OPPOSITION TO PLAINTIFFS MOTION TO STRIKE INEQUITABLE CONDUCT AFFIRMATIVE DEFENSES AND INEQUITABLE CONDUCT COUNTERCLAIMS filed by Sandoz Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 02/28/2025) (30) |
| Feb 28, 2025 | 490 | MOTION For a Status Conference, And Notice of Partial Adoption and Joinder of Samsung Bioepis, Co., LTD's Scheduling Motion [ECF No. 478] by Celltrion, Inc., Celltrion, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Gottlieb, Max) (Entered: 02/28/2025) (5) |
| Feb 26, 2025 | 486 | MOTION to Withdraw as Attorney (John Pizzo) by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 02/26/2025) (2) |
| Feb 26, 2025 | 487 | MOTION to Withdraw as Attorney (John D. Pizzo) by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 02/26/2025) (2) |
| Feb 25, 2025 | 485 | REPLY to Response to Motion re (298 in 1:23-cv-00106-TSK-JPM) MOTION for Entry of Scheduling Order filed by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 02/25/2025) (8) |
| Feb 21, 2025 | 484 | Defendant Formycon AG's Other Document re (478 in 1:24-md-03103-TSK-JPM) MOTION to Partially Adopt and Join Samsung Bioepis, Co., Ltd.'s Motion for Entry of Scheduling Order Pursuant to Rule 16 or, in the Alternative, a Status Conference filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 02/21/2025) (6) |
| Feb 18, 2025 | 483 | RESPONSE in Opposition re (298 in 1:23-cv-00106-TSK-JPM) MOTION FOR ENTRY OF SCHEDULING ORDER PURSUANT TO RULE 16 OR, IN THE ALTERNATIVE, A STATUS CONFERENCE filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 02/18/2025) (0) |
| Feb 13, 2025 | 482 | REPLY to Response to Motion re (295 in 1:23-cv-00106-TSK-JPM) MOTION TO STRIKE SAMSUNG BIOEPIS'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSE AND TO DISMISS ITS INEQUITABLE CONDUCT COUNTERCLAIM filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 02/13/2025) (15) |
| Feb 11, 2025 | 481 | STIPULATION AND ORDER ENLARGING TIME TO FILE RESPONSE AND REPLY MEMORANDA TO PLAINTIFF'S MOTION TO STRIKE DEFENDANT'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSES AND TO DISMISS DEFENDANT'S INEQUITABLE COUNTERCLAIMS. Signed by Chief District Judge Thomas S. Kleeh on 02/11/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 02/11/2025) (4) |
| Feb 10, 2025 | 480 | STIPULATION AND ORDER ENLARGING TIME TO FILE RESPONSE AND REPLY MEMORANDA TO PLALINTIFF'S MOTION TO STRIKE DEFENDANT'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSES AND TO DISMISS DEFENDANT'S INEQUITABLE COUNTERCLAIMS by Sandoz Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 02/10/2025) (4) |
| Feb 6, 2025 | 479 | RESPONSE in Opposition re (315 in 1:23-cv-00094-TSK-JPM, 295 in 1:23-cv-00106-TSK-JPM, 472 in 1:24-md-03103-TSK-JPM) MOTION TO STRIKE SAMSUNG BIOEPIS'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSE AND TO DISMISS ITS INEQUITABLE CONDUCT COUNTERCLAIM filed by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, Part I, # 7 Exhibit F, Part II, # 8 Exhibit F, Part III, # 9 Exhibit G, Part I, # 10 Exhibit G, Part II, # 11 Exhibit H, # 12 Exhibit I, # 13 Exhibit J, # 14 Exhibit K)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 02/06/2025) (0) |
| Feb 3, 2025 | 478 | Motion for Entry of Scheduling Order Pursuant to Rule 16 or, in the Alternative, A Status Conference filed by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. (Attachments: # 1 Exhibit A to Motion for Entry of Scheduling Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) Modified to make a pending motion on 2/4/2025. NEF regen. (dk) (Entered: 02/03/2025) (0) |
| Jan 31, 2025 | 477 | MOTION to Strike Defendant's Inequitable Conduct Affirmative Defenses and to Dismiss Defendant's Inequitable Conduct Counterclaims by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Plaintiff's Memorandum of Law in Support of its Motion to Strike Defendant's Inequitable Conduct Affirmative Defenses and to Dismiss Defendant's Inequitable Conduct Counterclaims, # 2 Exhibit 1, # 3 Exhibit 2)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 01/31/2025) (0) |
| Jan 29, 2025 | 473 | OPINION of USCA for the FEDERAL CIRCUIT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD., (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA for the FEDERAL CIRCUIT Decision: AFFIRMED. (snc) (Entered: 01/29/2025) (30) |
| Jan 29, 2025 | 474 | USCA JUDGMENT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (snc) (Entered: 01/29/2025) (1) |
| Jan 29, 2025 | 475 | OPINION of USCA for the FEDERAL CIRCUIT as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG USCA Decision: AFFIRMED. (snc) (Entered: 01/29/2025) (16) |
| Jan 29, 2025 | 476 | USCA for the FEDERAL CIRCUIT JUDGMENT as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG. (snc) (Entered: 01/29/2025) (1) |
| Jan 23, 2025 | 471 | Other Document PLAINTIFF REGENERON PHARMACEUTICALS, INC.'S ANSWER TO DEFENDANT FORMYCON AG'S COUNTERCLAIMS filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 01/23/2025) (30) |
| Jan 23, 2025 | 472 | MOTION TO STRIKE SAMSUNG BIOEPIS'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSE AND TO DISMISS ITS INEQUITABLE CONDUCT COUNTERCLAIM by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment PLAINTIFF'S MEMORANDUM OF LAW IN SUPPORT OF ITS MOTION TO STRIKE SAMSUNG BIOEPIS'S INEQUITABLE CONDUCT AFFIRMATIVE DEFENSE AND TO DISMISS ITS INEQUITABLE CONDUCT COUNTERCLAIM, # 2 Exhibit 1)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 01/23/2025) (0) |
| Jan 21, 2025 | 470 | STIPULATION TO EXTEND ANSWER DEADLINE. The time for Regeneron to respond to Sandoz's First Amended Answer to Complaint, Defenses, and Counterclaims is extended by one week to January 31, 2025. Signed by Chief District Judge Thomas S. Kleeh on 01/21/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 01/21/2025) (4) |
| Jan 20, 2025 | 469 | STIPULATION TO EXTEND ANSWER DEADLINE by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 01/20/2025) (5) |
| Jan 14, 2025 | 467 | MOTION to Withdraw as Attorney - Thomas H Ehrich by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 01/14/2025) (2) |
| Jan 14, 2025 | 468 | ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF NO. 467 ). Attorney Thomas H. Ehrich terminated in case 1:24-md-03103-TSK-JPM and in case 1:22-cv-00061-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 01/14/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 01/14/2025) (1) |
| Jan 13, 2025 | 466 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 464 ). Signed by Chief District Judge Thomas S. Kleeh on 01/13/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 01/13/2025) (1) |
| Jan 10, 2025 | 464 | MOTION for Leave to File UNDER SEAL by Sandoz Inc.. (Attachments: # 1 Attachment, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 01/10/2025) (0) |
| Jan 7, 2025 | 460 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 452 , 454 , 455 . Signed by Chief District Judge Thomas S. Kleeh on 01/07/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 01/07/2025) (1) |
| Jan 7, 2025 | 461 | STIPULATION TO EXTEND ANSWER DEADLINES. Signed by Chief District Judge Thomas S. Kleeh on 01/07/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 01/07/2025) (4) |
| Jan 7, 2025 | 462 | ORDER GRANTING JOINT MOTION TO STRIKE JOINT STIPULATION (ECF No. 235 ) FROM DOCKET. Signed by Chief District Judge Thomas S. Kleeh on 01/07/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 01/07/2025) (4) |
| Jan 7, 2025 | 463 | STIPULATED PROTECTIVE ORDER. Signed by Chief District Judge Thomas S. Kleeh on 01/07/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 01/07/2025) (30) |
| Jan 2, 2025 | 452 | MOTION for Leave to File Under Seal by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Memorandum in Support of Defendant's Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 01/02/2025) (0) |
| Jan 2, 2025 | 454 | MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM(Law, Sandra) (Entered: 01/02/2025) (0) |
| Jan 2, 2025 | 455 | MOTION for Leave to File Under Seal by Samsung Bioepis Co., Ltd., Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 01/02/2025) (0) |
| Jan 2, 2025 | 456 | STIPULATION for One Day Extension by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 01/02/2025) (5) |
| Dec 31, 2024 | 451 | Joint MOTION to Strike Joint Stipulation (ECF 235) from Docket by Celltrion, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Gottlieb, Max) (Entered: 12/31/2024) (0) |
| Dec 27, 2024 | 450 | STIPULATION and Joint Request for Entry of Agreed Protective Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Stipulated Protective Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Ruby, Steven) (Entered: 12/27/2024) (0) |
| Dec 26, 2024 | 448 | ANSWER to Complaint and Separate Defenses by Celltrion, Inc., Celltrion, Inc..Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Gottlieb, Max) (Entered: 12/26/2024) (30) |
| Dec 26, 2024 | 449 | ANSWER to Complaint and Separate Defenses by Celltrion, Inc., Celltrion, Inc..Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK(Gottlieb, Max) (Entered: 12/26/2024) (30) |
| Dec 13, 2024 | 446 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 440 , 442 , 444 . Signed by Chief District Judge Thomas S. Kleeh on 12/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 12/13/2024) (1) |
| Dec 13, 2024 | 447 | NOTICE of Change of Address by Sandra K. Law Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 12/13/2024) (3) |
| Dec 12, 2024 | 435 | STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND. Regeneron shall file its First Amended Complaint within two (2) days of the date the Court signs and orders this Stipulation or on December 2, 2024, whichever is later, and SB shall file its answer to Regeneron's First Amended Complaint no later than twenty-one (21) days following the filing of Regeneron's First Amended Complaint. Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) (Entered: 12/12/2024) (5) |
| Dec 12, 2024 | 436 | STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND. Regeneron will file its First Amended Complaint within two (2) days of the date the Court signs and orders this Stipulation or on December 2, 2024, whichever is later. Formycon will file its answer or otherwise respond to Regeneron's First Amended Complaint no later than twenty-one (21) days following the filing of Regeneron's First AmendedComplaint. Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 12/12/2024) (5) |
| Dec 12, 2024 | 437 | STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND. Regeneron shall file its First Amended Complaint within two (2) days of the date the Court signs and orders this Stipulation or on December 2, 2024, whichever is later, and SB shall file its answer to Regeneron's First Amended Complaint no later than twenty-one (21) days following the filing of Regeneron's First Amended Complaint. Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM(snc) (Entered: 12/12/2024) (5) |
| Dec 12, 2024 | 438 | MOTION to Withdraw as Attorney ANISH R. DESAI, KATHRYN LEICHT, KELLIE VAN BECK, MATTHEW D. SEIGER, NATALIE C. KENNEDY, TOM YU, AND ZHEN LIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/12/2024) (4) |
| Dec 12, 2024 | 439 | ORDER. For good cause, the following motions to withdraw are GRANTED: ECF Nos. 426 , 427 , 438 . The Clerk SHALL terminate Jennifer Brooks Crozier, Rocco Recce, Anish R. Desai, Kathryn Leicht, Kellie Van Beck, Matthew D. Sieger, Natalie C. Kennedy, Tom Yu, and Zhen Lin as counsel of record in this matter. Additionally, for good cause, the following motions to seal are GRANTED: ECF Nos. 429 , 431 . Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 12/12/2024) (1) |
| Dec 12, 2024 | 440 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 12/12/2024) (0) |
| Dec 12, 2024 | 442 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM(Pogue, David) (Entered: 12/12/2024) (0) |
| Dec 12, 2024 | 444 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 12/12/2024) (0) |
| Dec 10, 2024 | 434 | MOTION to Strike Defendant's Inequitable Affirmative Defenses and to Dismiss Defendant's Inequitable Conduct Counterclaim by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Plaintiff's Memorandum of Law in Support of its Motion to Strike Defendant's Inequitable Affirmative Defenses and to Dismiss Defendant's Inequitable Conduct Counterclaim, # 2 Exhibit 1, # 3 Exhibit 2)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 12/10/2024) (0) |
| Dec 9, 2024 | 433 | NOTICE of Change of Address by David R. Pogue Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/09/2024) (3) |
| Dec 5, 2024 | 429 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Pogue, David) (Entered: 12/05/2024) (0) |
| Dec 5, 2024 | 431 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 12/05/2024) (0) |
| Dec 4, 2024 | 422 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 417 , 420 . Signed by Chief District Judge Thomas S. Kleeh on 12/04/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(snc) (Entered: 12/04/2024) (1) |
| Dec 4, 2024 | 423 | STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND. Celltrion will file its answer to Regeneron's First Amended Complaint no later than twenty-one (21) days following the filing of Regeneron's First Amended Complaint. Regeneron will file its First Amended Complaint within two business days of this stipulation being signed by the Court. Signed by Chief District Judge Thomas S. Kleeh on 12/04/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK (snc) (Entered: 12/04/2024) (5) |
| Dec 4, 2024 | 424 | STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND. Celltrion will file its answer to Regeneron's First Amended Complaint no later than twenty-one (21) days following the filing of Regeneron's First Amended Complaint. Regeneron will file its First Amended Complaint within two business days of this stipulation being signed by the Court. Signed by Chief District Judge Thomas S. Kleeh on 12/04/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 12/04/2024) (5) |
| Dec 4, 2024 | 425 | NOTICE of Change of Address by David R. Pogue Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (3) |
| Dec 4, 2024 | 426 | MOTION to Withdraw as Attorney JENNIFER BROOKS CROZIER'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (4) |
| Dec 4, 2024 | 427 | MOTION to Withdraw as Attorney ROCCO RECCE'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (4) |
| Dec 4, 2024 | 428 | CERTIFICATE OF SERVICE by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. documents bearing production numbers BBI-AFL-BLA0002802 BBI-AFL-BLA0021883. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 12/04/2024) (2) |
| Dec 2, 2024 | 414 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 406 , 408 , 412 . Signed by Chief District Judge Thomas S. Kleeh on 12/02/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 12/02/2024) (1) |
| Dec 2, 2024 | 415 | STIPULATION TO EXTEND ANSWER DEADLINES. The time for Celltrion to file its answers to Regeneron's original Complaints is extended to December 3, 2024. Signed by Chief District Judge Thomas S. Kleeh on 12/02/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK (snc) (Entered: 12/02/2024) (5) |
| Dec 2, 2024 | 416 | STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - First Amended Complaint (to be filed under seal))Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Pogue, David) (Entered: 12/02/2024) (0) |
| Dec 2, 2024 | 417 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Pogue, David) (Entered: 12/02/2024) (0) |
| Dec 2, 2024 | 419 | STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - First Amended Complaint (to be filed under seal))Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 12/02/2024) (0) |
| Dec 2, 2024 | 420 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 12/02/2024) (0) |
| Nov 26, 2024 | 406 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM(Pogue, David) (Entered: 11/26/2024) (0) |
| Nov 26, 2024 | 408 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 11/26/2024) (0) |
| Nov 26, 2024 | 410 | STIPULATION TO EXTEND ANSWER DEADLINES by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 11/26/2024) (6) |
| Nov 26, 2024 | 411 | STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - First Amended Complaint (to be filed under seal))Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 11/26/2024) (0) |
| Nov 26, 2024 | 412 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 11/26/2024) (0) |
| Nov 22, 2024 | 405 | STIPULATION AND BRIEFING SCHEDULE. Regeneron to file an answer or motion in response to Sandoz's counterclaims is extended to December 10, 2024. Sandoz's response to any such motion shall be due January 10, 2025. Regeneron's reply to Sandoz's response shall be due January 24, 2025. Signed by Chief District Judge Thomas S. Kleeh on 11/22/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (jb) (Entered: 11/22/2024) (4) |
| Nov 20, 2024 | 401 | STIPULATION TO EXTEND ANSWER DEADLINE. The time for Formycon to file its answer to Regeneron's Complaint is extended to November 26, 2024. Signed by Chief District Judge Thomas S Kleeh on 11/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (dk) (Entered: 11/20/2024) (4) |
| Nov 20, 2024 | 402 | STIPULATION TO EXTEND ANSWER DEADLINES. The time for Celltrion to file its answers to Regeneron's original Complaints is extended to November 26, 2024. Signed by Chief District Judge Thomas S Kleeh on 11/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK (dk) (Entered: 11/20/2024) (5) |
| Nov 20, 2024 | 403 | STIPULATION TO EXTEND ANSWER DEADLINES. The time for SB to file its answers to Regenerons Complaints is extended to November 26, 2024. Signed by Chief District Judge Thomas S Kleeh on 11/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (dk) (Entered: 11/20/2024) (4) |
| Nov 20, 2024 | 404 | STIPULATION AND PROPOSED BRIEFING SCHEDULE by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 11/20/2024) (5) |
| Nov 19, 2024 | 398 | STIPULATION TO EXTEND ANSWER DEADLINE by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 11/19/2024) (5) |
| Nov 19, 2024 | 399 | STIPULATION TO EXTEND ANSWER DEADLINES by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 11/19/2024) (6) |
| Nov 19, 2024 | 400 | STIPULATION TO EXTEND ANSWER DEADLINES by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 11/19/2024) (5) |
| Nov 15, 2024 | 397 | ORDER GRANTING MOTIONS TO WITHDRAW AS COUNSEL (ECF NOS. 394 , 395 ). Signed by Chief District Judge Thomas S. Kleeh on 11/15/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 11/15/2024) (1) |
| Nov 14, 2024 | 394 | MOTION to Withdraw as Attorney SEAN M. DOUGLASS' MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 11/14/2024) (4) |
| Nov 14, 2024 | 395 | MOTION to Withdraw as Attorney REBECCA CARTER'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 11/14/2024) (4) |
| Nov 14, 2024 | 396 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. for Amgen's Responses to Regeneron's Third Set of Requests for Production of Documents and Things (No. 27). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McMillan, Stuart) (Entered: 11/14/2024) (2) |
| Nov 13, 2024 | 391 | STIPULATION TO EXTEND ANSWER DEADLINES. The time for Celltrion to file its answers to Regeneron's original Complaints is extended to November 19, 2024. Signed by Chief District Judge Thomas S. Kleeh on 11/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(snc) Modified to add docket text on 11/13/2024 (snc). (Entered: 11/13/2024) (5) |
| Nov 13, 2024 | 392 | STIPULATION TO EXTEND ANSWER DEADLINES. The time for SB to file its answers to Regeneron's Complaints is extended to November 19, 2024. Signed by Chief District Judge Thomas S. Kleeh on 11/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(snc) (Entered: 11/13/2024) (4) |
| Nov 13, 2024 | 393 | ORDER STIPULATION AND ORDER. The time for Formycon to file its answer to Regeneron's Complaint is extended to November 19, 2024. Signed by Chief District Judge Thomas S Kleeh on 11/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 11/13/2024) (4) |
| Nov 12, 2024 | 388 | STIPULATION TO EXTEND ANSWER DEADLINES by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 11/12/2024) (5) |
| Nov 12, 2024 | 389 | STIPULATION TO EXTEND ANSWER DEADLINE by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 11/12/2024) (5) |
| Nov 12, 2024 | 390 | STIPULATION TO EXTEND ANSWER DEADLINES by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 11/12/2024) (6) |
| Nov 6, 2024 | 387 | REPLY to Response to Motion re (835 in 1:22-cv-00061-TSK-JPM) MOTION for Leave to File Reply in Support of Regeneron's Objections to the Magistrate Judge's Order Denying Motion to Lift the March 26, 2024 Order's Prosecution Bar filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 11/06/2024) (6) |
| Oct 31, 2024 | 385 | ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF NO. 378 ). Ms. Anderson shall be TERMINATED as counsel of record in this matter. Signed by Chief District Judge Thomas S. Kleeh on 10/31/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 10/31/2024) (1) |
| Oct 31, 2024 | 386 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 381 ). Signed by Chief District Judge Thomas S. Kleeh on 10/31/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (snc) (Entered: 10/31/2024) (1) |
| Oct 30, 2024 | 378 | MOTION to Withdraw as Attorney HAYLEE BERNAL ANDERSON'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 10/30/2024) (4) |
| Oct 30, 2024 | 379 | RESPONSE in Opposition re (835 in 1:22-cv-00061-TSK-JPM, 377 in 1:24-md-03103-TSK-JPM) MOTION for Leave to File Reply in Support of Regeneron's Objections to the Magistrate Judge's Order Denying Motion to Lift the March 26, 2024 Order's Prosecution Bar filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 10/30/2024) (9) |
| Oct 30, 2024 | 381 | Motion for Leave to File Under Seal filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (Wakefield, Jeffrey) (Entered: 10/30/2024) (3) |
| Oct 30, 2024 | 382 | Proposed Granting Motion for Leave to File Under Seal Order by Sandoz Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 10/30/2024) (1) |
| Oct 30, 2024 | 383 | MEMORANDUM Memorandum of Law in Support of Motion for Leave to File Under Seal by Sandoz Inc. . Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 10/30/2024) (5) |
| Oct 30, 2024 | 384 | Corporate Disclosure Statement by Sandoz Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 10/30/2024) (3) |
| Oct 22, 2024 | 376 | ORDER of USCA for the Federal Circuit as to 344 in 1:24-md-03103-TSK-JPM Notice of Appeal and 258 in 1:24-cv-00039-TSK-JPM Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. (snc) (Entered: 10/22/2024) (3) |
| Oct 22, 2024 | 377 | MOTION for Leave to File Reply in Support of Regeneron's Objections to the Magistrate Judge's Order Denying Motion to Lift the March 26, 2024 Order's Prosecution Bar by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Reply in Support of Regeneron's Objections to the Magistrate Judge's Order Denying Motion to Lift the March 26, 2024 Order's Prosecution Bar)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 10/22/2024) () (4) |
| Oct 22, 2024 | 377 | MOTION for Leave to File Reply in Support of Regeneron's Objections to the Magistrate Judge's Order Denying Motion to Lift the March 26, 2024 Order's Prosecution Bar by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Reply in Support of Regeneron's Objections to the Magistrate Judge's Order Denying Motion to Lift the March 26, 2024 Order's Prosecution Bar)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 10/22/2024) (Attachment Reply in Support of Regeneron's Objections to the Magistrate Jud) (16) |
| Oct 21, 2024 | 373 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL AND SUBSTITUTE (ECF NO. 364 ). Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(snc) (Entered: 10/21/2024) (1) |
| Oct 21, 2024 | 374 | STIPULATION AND ORDER REGARDING CASE MANAGEMENT. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 10/21/2024) (7) |
| Oct 21, 2024 | 375 | ORDER STIPULATION AND ORDER. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK (snc) (Entered: 10/21/2024) (4) |
| Oct 18, 2024 | 372 | STIPULATION Regarding Case Management by Celltrion, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK(Gottlieb, Max) (Entered: 10/18/2024) (5) |
| Oct 16, 2024 | 369 | PROOF OF SERVICE filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (Pogue, David) (Entered: 10/16/2024) (2) |
| Oct 16, 2024 | 370 | PROOF OF SERVICE filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (Pogue, David) (Entered: 10/16/2024) (2) |
| Oct 16, 2024 | 371 | PROOF OF SERVICE filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (Pogue, David) (Entered: 10/16/2024) (2) |
| Oct 15, 2024 | 366 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Third Requests for Production of Documents and Things to Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 10/15/2024) (1) |
| Oct 15, 2024 | 367 | MEMORANDUM Defendants Response to Regenerons Objections to Magistrate Judge Mazzones Order Denying Regenerons Motion to Lift the Prosecution Bar by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. re (833 in 1:22-cv-00061-TSK-JPM) Objections, . (Attachments: # 1 Exhibit Exhibit A)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 10/15/2024) () (29) |
| Oct 15, 2024 | 368 | STIPULATION and Proposed Order Regarding Case Management by Celltrion, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Gottlieb, Max) (Entered: 10/15/2024) (9) |
| Oct 15, 2024 | 367 | MEMORANDUM Defendants Response to Regenerons Objections to Magistrate Judge Mazzones Order Denying Regenerons Motion to Lift the Prosecution Bar by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. re (833 in 1:22-cv-00061-TSK-JPM) Objections, . (Attachments: # 1 Exhibit Exhibit A)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 10/15/2024) (Exhibit Exhibit A) (19) |
| Oct 10, 2024 | 364 | MOTION for Leave to File UNDER SEAL - MOTION FOR LEAVE TO FILE AND SUBSTITUTE CORRECT EXHIBIT 5 TO REGENERON'S OPPOSITION TO CELLTRION'S MOTION TO DISMISS UNDER SEAL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Pogue, David) (Entered: 10/10/2024) (5) |
| Oct 8, 2024 | 363 | ORDER APPROVING APPLICATIONS TO APPEAR PRO HAC VICE for Emily L. Rapalino [ECF No. 354 ]; Grace Truong [ECF No. 355 ], Joshua Weinger [ECF No. 356 ], Louis L. Lobel [ECF No. 357 ], Molly R. Grammel [ECF No. 358 ], Timothy James Beavers [ECF No. 359 ], Christopher Cassella [ECF No. 360 ] and Elaine Herrmann Blais [ECF No. 361 ]. Signed by Chief District Judge Thomas S. Kleeh on 10/8/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (jb) (Entered: 10/08/2024) (1) |
| Oct 2, 2024 | 354 | MOTION/Application for Admission Pro Hac Vice of Emily L. Rapalino Other Document filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (Wakefield, Jeffrey) (Main Document 354 replaced with flattened document and modified to make pending motion on 10/2/2024) (dk). (Entered: 10/02/2024) (4) |
| Oct 2, 2024 | 355 | MOTION/Application for Admission Pro Hac Vice of Grace Truong Other Document filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (Wakefield, Jeffrey) (Main Document 355 replaced with flattened document and modified to make pending motion on 10/2/2024) (dk). (Entered: 10/02/2024) (3) |
| Oct 2, 2024 | 356 | MOTION/Application for Admission Pro Hac Vice of Joshua Weinger Other Document filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (Wakefield, Jeffrey) (Main Document 356 replaced with flattened document and modified to make pending motion on 10/2/2024) (dk). (Entered: 10/02/2024) (3) |
| Oct 2, 2024 | 357 | MOTION/Application for Admission Pro Hac Vice of Louis L. Lobel Other Document filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (Wakefield, Jeffrey) (Main Document 357 replaced with flattened document and modified to make pending motion on 10/2/2024) (dk). (Entered: 10/02/2024) (3) |
| Oct 2, 2024 | 358 | MOTION/Application for Admission Pro Hac Vice of Molly R. Grammel Other Document filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (Wakefield, Jeffrey) (Main Document 358 replaced with flattened document and modified to make pending motion on 10/2/2024) (dk). (Entered: 10/02/2024) (4) |
| Oct 2, 2024 | 359 | MOTION/Application for Admission Pro Hac Vice of Timothy James Beavers Other Document filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (Wakefield, Jeffrey) (Main Document 359 replaced with flattened document and modified to make pending motion on 10/2/2024) (dk). (Entered: 10/02/2024) (3) |
| Oct 2, 2024 | 360 | MOTION/Application for Admission Pro Hac Vice of Christopher Cassella Other Document filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) Modified to make pending motion and replace with flattened document on 10/2/2024 (dk). (Entered: 10/02/2024) (3) |
| Oct 2, 2024 | 361 | MOTION/Application for Admission Pro Hac Vice of Elaine Herrmann Blais Other Document filed by Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Main Document 361 replaced with flattened document and modified to make a pending motion on 10/2/2024) (dk). (Entered: 10/02/2024) (4) |
| Oct 2, 2024 | 362 | Pro Hac Vice Filing Fee in the amount of $1,600.00 for Emily L. Rapalino, Grace Truong, Joshua Weinger, Louis L. Lobel, Molly R. Grammel, Timothy James Beavers, Christopher Cassella and Elaine Herrmann Blais. Receipt Number: 100003953. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(jb) (Entered: 10/02/2024) (0) |
| Oct 1, 2024 | 352 | REDACTED ORDER DENYING REGENERON'S MOTION FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 09/23/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 10/01/2024) (30) |
| Oct 1, 2024 | 353 | OBJECTIONS to (828 in 1:22-cv-00061-TSK-JPM) Order, by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit Declaration of Ellen Oberwetter in Support of Regeneron's Objections to the Magistrate Judge's Order Denying Motion to Lift the March 26, 2024 Order's Prosecution Bar)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 10/01/2024) () (27) |
| Oct 1, 2024 | 353 | OBJECTIONS to (828 in 1:22-cv-00061-TSK-JPM) Order, by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit Declaration of Ellen Oberwetter in Support of Regeneron's Objections to the Magistrate Judge's Order Denying Motion to Lift the March 26, 2024 Order's Prosecution Bar)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 10/01/2024) (Exhibit Declaration of Ellen Oberwetter in Support of Regeneron's Objection) (2) |
| Sep 27, 2024 | 350 | RESPONSE to Motion re (27 in 1:24-cv-00053-TSK, 334 in 1:24-md-03103-TSK-JPM, 261 in 1:23-cv-00106-TSK-JPM, 266 in 1:23-cv-00097-TSK-JPM, 254 in 1:24-cv-00039-TSK-JPM, 278 in 1:23-cv-00094-TSK-JPM, 215 in 1:23-cv-00089-TSK-JPM) MOTION for Status Conference filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 09/27/2024) (5) |
| Sep 27, 2024 | 351 | REPLY to Response to Motion re (824 in 1:22-cv-00061-TSK-JPM) MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing Defendants Biocon Biologics Inc.s and Mylan Pharmaceuticals Inc.s Reply in Support of Motion To Unseal Portions of the August 13, 2024 Hearing Transcript and Related Briefing filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 09/27/2024) (6) |
| Sep 25, 2024 | 347 | STIPULATION Enlarging Time to Answer Complaint by Sandoz Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 09/25/2024) (1) |
| Sep 25, 2024 | 348 | NOTICE of Appearance by Morgan Elizabeth Villers on behalf of Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Villers, Morgan) (Entered: 09/25/2024) (2) |
| Sep 25, 2024 | 349 | ORDER ISSUED AS PER CURIAM of USCA for the Federal Circuit as to 344 in 1:24-md-03103-TSK-JPM and 258 in 1:24-cv-00039-TSK-JPM Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. (snc) (Entered: 09/25/2024) (2) |
| Sep 24, 2024 | 345 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 344 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Additional attachment(s) added on 9/24/2024: # 4 Sealed Order) (snc). (Attachment 2 replaced on 9/24/2024) (snc). (Entered: 09/24/2024) () (1) |
| Sep 24, 2024 | 346 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 344 in 1:24-md-03103-TSK-JPM and 258 in 1:24-cv-00039-TSK-JPM. Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. USCA for the Federal Circuit Case Number: 2024-2351. (snc) (Entered: 09/24/2024) (4) |
| Sep 24, 2024 | 345 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 344 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Additional attachment(s) added on 9/24/2024: # 4 Sealed Order) (snc). (Attachment 2 replaced on 9/24/2024) (snc). (Entered: 09/24/2024) (Attorney List) (25) |
| Sep 24, 2024 | 345 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 344 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Additional attachment(s) added on 9/24/2024: # 4 Sealed Order) (snc). (Attachment 2 replaced on 9/24/2024) (snc). (Entered: 09/24/2024) (Docket Sheet) (30) |
| Sep 24, 2024 | 345 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 344 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Additional attachment(s) added on 9/24/2024: # 4 Sealed Order) (snc). (Attachment 2 replaced on 9/24/2024) (snc). (Entered: 09/24/2024) (Notice of Appeal) (4) |
| Sep 23, 2024 | 342 | TRANSCRIPT of Proceedings held on 9/5/2024, before Judge Mazzone. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 10/15/2024. Redacted Transcript Deadline set for 10/24/2024. Release of Transcript Restriction set for 12/23/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(ck) (Entered: 09/23/2024) (0) |
| Sep 23, 2024 | 343 | ***SEALED***ORDER DENYING REGENERON'S MOTION FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 09/23/2024. (Copy to counsel for Regeneron and Amgen ONLY) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/23/2024) (0) |
| Sep 23, 2024 | 344 | NOTICE OF APPEAL by Regeneron Pharmaceuticals, Inc.. Filing fee $; 605, receipt number WVNDC-4016637. (Ruby, Steven) (Entered: 09/23/2024) (4) |
| Sep 20, 2024 | 338 | AMENDED ORDER DENYING REGENERON PHARMACEUTICALS, INC.'S MOTION 275 TO LIFT THE MARCH 26, 2024 ORDER'S PROSECUTION BAR. Signed by Magistrate Judge James P. Mazzone on 09/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 09/20/2024) (7) |
| Sep 20, 2024 | 339 | NOTICE of Appearance by Jeffrey M. Wakefield on behalf of Sandoz Inc. (Wakefield, Jeffrey) (Entered: 09/20/2024) (1) |
| Sep 20, 2024 | 340 | Memorandum in Opposition re (824 in 1:22-cv-00061-TSK-JPM, 327 in 1:24-md-03103-TSK-JPM) MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing filed by Amgen, Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM, 1:24-cv-00039-TSK-JPM(McMillan, Stuart) (Entered: 09/20/2024) (6) |
| Sep 20, 2024 | 341 | CORRECTED NOTICE of Appearance by Jeffrey M. Wakefield on behalf of Sandoz Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK (Wakefield, Jeffrey) (Entered: 09/20/2024) (1) |
| Sep 18, 2024 | 337 | MOTION Joinder in Motion for Status Conference by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 09/18/2024) (3) |
| Sep 17, 2024 | 336 | ORDER DENYING REGENERON PHARMACEUTICALS, INC.'S MOTION 275 TO LIFT THE MARCH 26, 2024 ORDER'S PROSECUTION BAR. Signed by Magistrate Judge James P. Mazzone on 09/17/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 09/17/2024) (7) |
| Sep 13, 2024 | 332 | MEMBER CASE OPENED: Case Transferred into the Northern District of West Virginia: District of New Jersey, 2:24-cv-08760, REGENERON PHARMACEUTICALS, INC. v. SANDOZ INC. as NDWV case 1:24-cv-85 pursuant to 331 CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) and filed the 24 Pretrial Order #1: INITIAL SCHEDULING CONFERENCE. (snc) (Entered: 09/13/2024) (0) |
| Sep 13, 2024 | 333 | STIPULATION TO SUPPLEMENT PRELIMINARY INJUNCTION RECORD by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit A _ Approval Letter)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 09/13/2024) () (5) |
| Sep 13, 2024 | 334 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) () (8) |
| Sep 13, 2024 | 335 | ORDER of USCA for the Federal Circuit as to 259 Notice of Appeal filed by Samsung Bioepis Co., Ltd., 190 Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., 258 Notice of Appeal filed by Samsung Bioepis, CO., LTD., 175 Notice of Appeal, filed by Samsung Bioepis, CO., LTD., 203 Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, 176 Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) (3) |
| Sep 13, 2024 | 333 | STIPULATION TO SUPPLEMENT PRELIMINARY INJUNCTION RECORD by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit A _ Approval Letter)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 09/13/2024) (Exhibit A _ Approval Letter) (8) |
| Sep 13, 2024 | 334 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. A) (6) |
| Sep 13, 2024 | 334 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. B) (18) |
| Sep 13, 2024 | 334 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. C) (30) |
| Sep 13, 2024 | 334 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. D) (12) |
| Sep 12, 2024 | 330 | ORDER granting 328 Motion for Leave to Appear Pro Hac Vice (Jeffrey A. Lamken) in case 1:24-md-03103-TSK-JPM; (250) Motion in 1:24-cv-00039-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 09/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/12/2024) (1) |
| Sep 12, 2024 | 331 | JPML CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) - 1 action(s) re: pldg. ( 45 in MDL No. 3103, 1 in NJ/2:24-cv-08760) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Acting Clerk of the Panel Marcella R. Lockert on 9/12/2024. Associated Cases: MDL No. 3103, NJ/2:24-cv-08760. (snc) (Entered: 09/12/2024) (2) |
| Sep 11, 2024 | 328 | MOTION for Leave to Appear Pro Hac Vice Jeffrey A. Lamken by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 09/11/2024) () (2) |
| Sep 11, 2024 | 329 | Pro Hac Vice Filing fee: $ 200.00, receipt number 100003945. (For Jeffrey Lamken) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/11/2024) (0) |
| Sep 11, 2024 | 328 | MOTION for Leave to Appear Pro Hac Vice Jeffrey A. Lamken by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 09/11/2024) (Proposed Order Proposed Order) (1) |
| Sep 6, 2024 | 327 | MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Appendix Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 09/06/2024) () (8) |
| Sep 6, 2024 | 327 | MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Appendix Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 09/06/2024) (Exhibit 1) (6) |
| Sep 6, 2024 | 327 | MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Appendix Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 09/06/2024) (Exhibit 2) (8) |
| Sep 6, 2024 | 327 | MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Appendix Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 09/06/2024) (Exhibit 3) (29) |
| Sep 6, 2024 | 327 | MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Appendix Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 09/06/2024) (Exhibit 4) (6) |
| Sep 6, 2024 | 327 | MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Appendix Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 09/06/2024) (Exhibit 5) (5) |
| Sep 6, 2024 | 327 | MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Appendix Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 09/06/2024) (Appendix Proposed Order) (3) |
| Sep 5, 2024 | 326 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Magistrate Judge James P. Mazzone: Oral Argument Hearing held on 9/5/2024 re ( 812 in 1:22-cv-00061-TSK-JPM, 275 in 1:24-md-03103-TSK-JPM) MOTION TO LIFT THE MARCH 26, 2024 ORDER'S PROSECUTION BAR AS TO CERTAIN ATTORNEYS AND LAW FIRMS filed by Regeneron Pharmaceuticals, Inc.. (Tape #WHG Mazzone 1 24 md 3103 and 1 22 cv 61 Regeneron v Mylan 9 5 24) Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(ag) (Entered: 09/05/2024) (0) |
| Sep 3, 2024 | 325 | ORDER GRANTING MOTIONS TO WITHDRAW. For good cause, they are GRANTED (ECF Nos. 323 , 324 ). Renee M. Griffin and Yi Zhang shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 09/03/2024) (1) |
| Aug 30, 2024 | 323 | MOTION to Withdraw as Attorney RENEE M. GRIFFIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) (4) |
| Aug 30, 2024 | 324 | MOTION to Withdraw as Attorney YI ZHANG'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) (4) |
| Aug 26, 2024 | 322 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL [ECF NO. 318 ]. Signed by Chief District Judge Thomas S. Kleeh on 8/26/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(jb) (Entered: 08/26/2024) (1) |
| Aug 22, 2024 | 321 | ORDER GRANTING UNOPPOSED MOTION 320 TO CONTINUE HEARING. Accordingly, the hearing currently set for August 23, 2024, is CANCELLED. The oral argument/evidentiary hearing regarding Regeneron's Motion 275 to Lift the March 26, 2024 Order's Prosecution Bar is NOW SET for September 5, 2024, at 10:00 a.m. in the Wheeling Magistrate Judge Courtroom, 4th Floor, before Magistrate Judge James P. Mazzone. Signed by Magistrate Judge James P. Mazzone on 08/22/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 08/22/2024) (1) |
| Aug 21, 2024 | 320 | Consent MOTION to Continue Unopposed Motion to Continue Hearing by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 08/21/2024) (3) |
| Aug 20, 2024 | 318 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 08/20/2024) () (4) |
| Aug 20, 2024 | 318 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 08/20/2024) (Attachment Memorandum in Support) (6) |
| Aug 20, 2024 | 318 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 08/20/2024) (Proposed Order) (1) |
| Aug 14, 2024 | 316 | TRANSCRIPT of Proceedings held on 8/13/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 9/4/2024. Redacted Transcript Deadline set for 9/16/2024. Release of Transcript Restriction set for 11/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(ck) (Entered: 08/14/2024) (0) |
| Aug 14, 2024 | 317 | *SEALED* TRANSCRIPT of Sealed Hearing held on 8/13/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(ck) (Entered: 08/14/2024) (0) |
| Aug 13, 2024 | 314 | ORDER SETTING ORAL ARGUMENT/EVIDENTIARY HEARING. An oral argument/evidentiary hearing is SET for August 23, 2024, at 10:00 a.m. in the Wheeling Magistrate Judge Courtroom, 4th Floor, before Magistrate Judge James P. Mazzone. Signed by Magistrate Judge James P. Mazzone on 08/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 08/13/2024) (1) |
| Aug 13, 2024 | 315 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S. Kleeh. Oral Argument Hearing re 157 Morion held on 8/13/2024. (Court Reporter Cindy Knecht) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/13/2024) (0) |
| Aug 12, 2024 | 313 | ORDER OF REFERRAL. The 275 motion is REFERRED to Magistrate Judge James P. Mazzone for disposition. Signed by Chief District Judge Thomas S. Kleeh on 08/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Main Document 313 replaced on 8/12/2024 to correct typo) (snc). (Entered: 08/12/2024) (1) |
| Aug 9, 2024 | 310 | ORDER ON MOTION of USCA for the Federal Circuit as to 176 in 1:24-md-03103-TSK-JPM and 226 in 1:23-cv-00106-TSK-JPM Notice of Appeal filed by Samsung Bioepis Co., Ltd. (snc) (Entered: 08/09/2024) (2) |
| Aug 9, 2024 | 311 | MOTION to Permit Entry to the Courthouse With Electronic Equipment by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 08/09/2024) () (4) |
| Aug 9, 2024 | 312 | ORDER GRANTING DEFENDANT AMGEN INC.'S 311 MOTION TO PERMIT ENTRY TO THE COURTHOUSE WITH ELECTRONIC EQUIPMENT. Signed by Chief District Judge Thomas S. Kleeh on 08/09/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/09/2024) (1) |
| Aug 9, 2024 | 311 | MOTION to Permit Entry to the Courthouse With Electronic Equipment by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 08/09/2024) (Proposed Order Proposed Order) (1) |
| Aug 2, 2024 | 309 | NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) () (4) |
| Aug 2, 2024 | 309 | NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) (Attachment July 23, 2024 Order ('572 patent)) (6) |
| Aug 2, 2024 | 309 | NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) (Attachment July 30, 2024 Judgment ('601 patent)) (4) |
| Aug 1, 2024 | 305 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 298 , 303 . Signed by Chief District Judge Thomas S. Kleeh on 08/01/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/01/2024) (1) |
| Aug 1, 2024 | 306 | ORDER granting 301 Motion to Withdraw as Attorney. Attorney Ashley Hardesty Odell terminated. Signed by Chief District Judge Thomas S. Kleeh on 08/01/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/01/2024) (1) |
| Aug 1, 2024 | 307 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re 254 in 1:23-cv-00097-TSK-JPM AND 261 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Formycon AG. Federal Circuit USCA Case Number: 24-2156. (snc) (Entered: 08/01/2024) (4) |
| Aug 1, 2024 | 308 | ORDER. Oral argument on Regeneron's motion 157 for preliminary injunction against Amgen is RESCHEDULED for August 13, 2024, from 9:00 a.m. until 11:00 a.m., at the Clarksburg, West Virginia, point of holding court. This is a change in location only. Signed by Chief District Judge Thomas S. Kleeh on 08/01/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/01/2024) (1) |
| Jul 31, 2024 | 301 | MOTION to Withdraw as Attorney by Amgen, Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 07/31/2024) (3) |
| Jul 31, 2024 | 302 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 269 in 1:24-md-03103-TSK-JPM and 204 in 1:23-cv-00089-TSK-JPM. Notice of Appeal filed by Celltrion, Inc. Federal Circuit USCA Case Number: 2024-2147. (snc) (Entered: 07/31/2024) (4) |
| Jul 31, 2024 | 303 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/31/2024) () (4) |
| Jul 31, 2024 | 303 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/31/2024) (Attachment Memorandum in Support) (6) |
| Jul 31, 2024 | 303 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/31/2024) (Proposed Order) (1) |
| Jul 30, 2024 | 300 | REPLY to Response to Motion re (812 in 1:22-cv-00061-TSK-JPM) MOTION TO LIFT THE MARCH 26, 2024 ORDER'S PROSECUTION BAR AS TO CERTAIN ATTORNEYS AND LAW FIRMS filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 07/30/2024) (6) |
| Jul 29, 2024 | 296 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 293 ). Signed by Chief District Judge Thomas S. Kleeh on 07/29/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/29/2024) (1) |
| Jul 29, 2024 | 297 | RESPONSE in Opposition re (812 in 1:22-cv-00061-TSK-JPM) MOTION TO LIFT THE MARCH 26, 2024 ORDER'S PROSECUTION BAR AS TO CERTAIN ATTORNEYS AND LAW FIRMS filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 07/29/2024) (5) |
| Jul 29, 2024 | 298 | MOTION for Leave to File UNDER SEAL - for Motion for Leave to File a Surreply by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/29/2024) () (3) |
| Jul 29, 2024 | 298 | MOTION for Leave to File UNDER SEAL - for Motion for Leave to File a Surreply by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/29/2024) (Memorandum in Support) (3) |
| Jul 29, 2024 | 298 | MOTION for Leave to File UNDER SEAL - for Motion for Leave to File a Surreply by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/29/2024) (Proposed Order) (1) |
| Jul 26, 2024 | 293 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 07/26/2024) () (4) |
| Jul 26, 2024 | 295 | ORDER. Oral argument on Regeneron's motion 157 for preliminary injunction against Amgen is CONTINUED until August 13, 2024, from 9:00 a.m. until 11:00 a.m., at the Elkins, West Virginia, point of holding court. Signed by Chief District Judge Thomas S. Kleeh on 07/26/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/26/2024) (1) |
| Jul 26, 2024 | 293 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 07/26/2024) (Attachment Memorandum in Support) (6) |
| Jul 26, 2024 | 293 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 07/26/2024) (Proposed Order) (1) |
| Jul 25, 2024 | 291 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 287 , 289 . Signed by Chief District Judge Thomas S. Kleeh on 07/25/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/25/2024) (1) |
| Jul 25, 2024 | 292 | ORDER. Oral argument on Regeneron's motion for preliminary injunction against Amgen 157 is SCHEDULED for August 6, 2024, between 10:00 a.m. and 12:00 p.m., at the Clarksburg, West Virginia, point of holding court. The parties SHALL email proposed orders on the preliminary injunction motion on or before August 9, 2024. Amgen's motion for guidance is DENIED AS MOOT [No. 283]. Signed by Chief District Judge Thomas S. Kleeh on 07/25/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/25/2024) (1) |
| Jul 25, 2024 | N/A | Set/Reset Deadlines as to Oral Argument Hearing re: 157 motion set for 8/6/2024 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/25/2024) (0) |
| Jul 24, 2024 | 282 | MOTION for Leave to File UNDER SEAL - for Motion for Guidance by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/24/2024) () (3) |
| Jul 24, 2024 | 284 | NOTICE of Appearance by Stuart A. McMillan on behalf of Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McMillan, Stuart) (Entered: 07/24/2024) (1) |
| Jul 24, 2024 | 285 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 279 , 282 . Signed by Chief District Judge Thomas S. Kleeh on 07/24/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/24/2024) (1) |
| Jul 24, 2024 | 286 | ORDER GRANTING MOTION TO WITHDRAW (ECF NO. 278 ). Terri L. Mascherin shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 07/24/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/24/2024) (1) |
| Jul 24, 2024 | 287 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) () (4) |
| Jul 24, 2024 | 289 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) () (4) |
| Jul 24, 2024 | 287 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) (Attachment Memorandum in Support) (6) |
| Jul 24, 2024 | 287 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) (Proposed Order) (1) |
| Jul 24, 2024 | 282 | MOTION for Leave to File UNDER SEAL - for Motion for Guidance by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/24/2024) (Memorandum in Support) (3) |
| Jul 24, 2024 | 282 | MOTION for Leave to File UNDER SEAL - for Motion for Guidance by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/24/2024) (Proposed Order) (1) |
| Jul 24, 2024 | 289 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) (Attachment Memorandum in Support) (6) |
| Jul 24, 2024 | 289 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) (Proposed Order) (1) |
| Jul 22, 2024 | 278 | MOTION to Withdraw as Attorney for Defendant Formycon AG by Terri L. Mascherin by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/22/2024) (3) |
| Jul 22, 2024 | 279 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/22/2024) () (3) |
| Jul 22, 2024 | 279 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/22/2024) (Memorandum in Support) (3) |
| Jul 22, 2024 | 279 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/22/2024) (Proposed Order) (1) |
| Jul 16, 2024 | 276 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 250 in 1:23-cv-00106-TSK-JPM and 259 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Samsung Bioepis Co., Ltd. Federal Circuit USCA Case Number: 2024-2082. (snc) (Entered: 07/16/2024) (4) |
| Jul 16, 2024 | 277 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 258 in 1:24-md-03103-TSK-JPM and 268 in 1:23-cv-00094-TSK-JPM. Notice of Appeal filed by Samsung Bioepis, CO., LTD. Federal Circuit USCA Case Number: 2024-2083. (snc) (Entered: 07/16/2024) (4) |
| Jul 15, 2024 | 272 | ***SEALED***ORDER ESTABLISHING SECURITY UNDER FEDERAL RULE OF CIVIL PROCEDURE 65(c). Signed by Chief District Judge Thomas S. Kleeh on 07/15/2024. (Copy to counsel for Regeneron and Celltrion only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/15/2024) (0) |
| Jul 15, 2024 | 273 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 262 , 264 . Signed by Chief District Judge Thomas S. Kleeh on 07/15/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 07/15/2024) (1) |
| Jul 15, 2024 | 274 | Other Document REGENERON'S RESPONSE TO AMGEN'S REQUEST FOR ORAL ARGUMENT filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/15/2024) (5) |
| Jul 15, 2024 | 275 | MOTION TO LIFT THE MARCH 26, 2024 ORDER'S PROSECUTION BAR AS TO CERTAIN ATTORNEYS AND LAW FIRMS by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 07/15/2024) () (6) |
| Jul 15, 2024 | 275 | MOTION TO LIFT THE MARCH 26, 2024 ORDER'S PROSECUTION BAR AS TO CERTAIN ATTORNEYS AND LAW FIRMS by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 07/15/2024) (Exhibit 1) (28) |
| Jul 15, 2024 | 275 | MOTION TO LIFT THE MARCH 26, 2024 ORDER'S PROSECUTION BAR AS TO CERTAIN ATTORNEYS AND LAW FIRMS by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 07/15/2024) (Proposed Order) (2) |
| Jul 12, 2024 | 261 | NOTICE OF APPEAL by Formycon AG. Filing fee $; 605, receipt number WVNDC-3974962. Appeal Record due by 7/10/2024. (Griffith, M.) (Entered: 07/12/2024) (3) |
| Jul 12, 2024 | 262 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) () (4) |
| Jul 12, 2024 | 264 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) () (4) |
| Jul 12, 2024 | 266 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 258 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) Modified on 7/12/2024 to correct docket number (snc). (Main Document 266 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) () (1) |
| Jul 12, 2024 | 267 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 259 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Main Document 267 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) () (1) |
| Jul 12, 2024 | 268 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Main Document 268 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) () (1) |
| Jul 12, 2024 | 269 | NOTICE OF APPEAL as to (188 in 1:23-cv-00089-TSK-JPM, 215 in 1:24-md-03103-TSK-JPM) Order on Motion to Seal, Sealed Motion (202 in 1:23-cv-00089-TSK-JPM, 252 in 1:24-md-03103-TSK-JPM) Order by Celltrion, Inc.. Filing fee $; 605, receipt number WVNDC-3975263. (Gottlieb, Max) (Entered: 07/12/2024) (3) |
| Jul 12, 2024 | 270 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 269 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/12/2024) () (1) |
| Jul 12, 2024 | 271 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. of Amgen's Responses to Regeneron's Second Set of Requests for Production of Documents and Things (Nos. 25-26). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/12/2024) (2) |
| Jul 12, 2024 | 264 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) (Attachment Memorandum in Support) (6) |
| Jul 12, 2024 | 264 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) (Proposed Order) (1) |
| Jul 12, 2024 | 266 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 258 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) Modified on 7/12/2024 to correct docket number (snc). (Main Document 266 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Attorney List) (23) |
| Jul 12, 2024 | 266 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 258 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) Modified on 7/12/2024 to correct docket number (snc). (Main Document 266 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Docket Sheet) (30) |
| Jul 12, 2024 | 266 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 258 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) Modified on 7/12/2024 to correct docket number (snc). (Main Document 266 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Notice of Appeal) (3) |
| Jul 12, 2024 | 266 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 258 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) Modified on 7/12/2024 to correct docket number (snc). (Main Document 266 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Final Order) (3) |
| Jul 12, 2024 | 270 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 269 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/12/2024) (Attorney List) (23) |
| Jul 12, 2024 | 270 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 269 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/12/2024) (Docket Sheet) (30) |
| Jul 12, 2024 | 270 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 269 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/12/2024) (Notice of Appeal) (3) |
| Jul 12, 2024 | 270 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 269 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/12/2024) (Final Order) (3) |
| Jul 12, 2024 | 267 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 259 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Main Document 267 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Attorney List) (23) |
| Jul 12, 2024 | 267 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 259 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Main Document 267 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Docket Sheet) (30) |
| Jul 12, 2024 | 267 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 259 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Main Document 267 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Notice of Appeal) (3) |
| Jul 12, 2024 | 267 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 259 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Main Document 267 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Final Order) (3) |
| Jul 12, 2024 | 262 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) (Attachment Memorandum in Support) (6) |
| Jul 12, 2024 | 262 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) (Proposed Order) (1) |
| Jul 12, 2024 | 268 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Main Document 268 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Attorney List) (23) |
| Jul 12, 2024 | 268 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Main Document 268 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Docket Sheet) (30) |
| Jul 12, 2024 | 268 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Main Document 268 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Notice of Appeal) (3) |
| Jul 12, 2024 | 268 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Main Document 268 replaced on 7/12/2024) (snc). (Entered: 07/12/2024) (Final Order) (3) |
| Jul 11, 2024 | 258 | NOTICE OF APPEAL by Samsung Bioepis, CO., LTD.,. Filing fee $; 605, receipt number WVNDC-3974210. Appeal Record due by 8/12/2024. (Law, Sandra) (Entered: 07/11/2024) (3) |
| Jul 11, 2024 | 259 | NOTICE OF APPEAL by Samsung Bioepis Co., Ltd.. Filing fee $; 605, receipt number WVNDC-3974213. Appeal Record due by 8/12/2024. (Law, Sandra) (Entered: 07/11/2024) (3) |
| Jul 11, 2024 | 260 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of David Blackburn, Ph.D.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/11/2024) (1) |
| Jul 10, 2024 | 252 | ORDER FOR INJUNCTIVE RELIEF AGAINST CELLTRION. Signed by Chief District Judge Thomas S. Kleeh on 07/10/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/10/2024) (3) |
| Jul 10, 2024 | 253 | ORDER FOR INJUNCTIVE RELIEF AGAINST FORMYCON. Signed by Chief District Judge Thomas S. Kleeh on 07/10/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/10/2024) (3) |
| Jul 10, 2024 | 254 | ORDER FOR INJUNCTIVE RELIEF AGAINST SAMSUNG BIOEPIS. Signed by Chief District Judge Thomas S. Kleeh on 07/10/2024. (Copy to counsel for Regeneron and Samsung only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) Modified to unseal per TSK Chambers (rr) on 7/11/2024 (snc). (Entered: 07/10/2024) (3) |
| Jul 10, 2024 | 255 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re 198 in 1:23-cv-00089-TSK-JPM and 241 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Celltrion, Inc. Federal Circuit USCA Case Number: 2024-2058. (snc) (Main Document 255 replaced on 7/12/2024) (snc). (Entered: 07/10/2024) (4) |
| Jul 10, 2024 | 256 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Brian Heath. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/10/2024) (1) |
| Jul 10, 2024 | 257 | NOTICE of Appearance by Karly King on behalf of Amgen, Inc., Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(King, Karly) (Entered: 07/10/2024) (1) |
| Jul 9, 2024 | 247 | Redacted Order Granting Motion for Preliminary Injunction. Signed by Chief District Judge Thomas S. Kleeh on 06/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/09/2024) (30) |
| Jul 9, 2024 | 248 | Redacted Order Granting Motion for Preliminary Injunction. Signed by Chief District Judge Thomas S. Kleeh on 06/28/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/09/2024) (30) |
| Jul 9, 2024 | 249 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 243 ). Signed by Chief District Judge Thomas S. Kleeh on 07/09/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 07/09/2024) (1) |
| Jul 9, 2024 | 250 | JOINT STIPULATION REGARDING RELATED MATTERS. Signed by Chief District Judge Thomas S. Kleeh on 07/09/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK (snc) (Entered: 07/09/2024) (6) |
| Jul 9, 2024 | 251 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Steven M. Chamow. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/09/2024) (1) |
| Jul 8, 2024 | 236 | ***SEALED***ORDER ESTABLISHING SECURITY UNDER FEDERAL RULE OF CIVIL PROCEDURE 65(c). Signed by Chief District Judge Thomas S. Kleeh on 07/08/2024. (Copy to counsel for Regeneron and Formycon only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/08/2024) (0) |
| Jul 8, 2024 | 237 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 227 , 229 , 234 . Signed by Chief District Judge Thomas S. Kleeh on 07/08/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/08/2024) (1) |
| Jul 8, 2024 | 238 | STIPULATION AND ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A JOINT PROPOSED REDACTED VERSION OF THE COURTS ORDER GRANTING MOTION FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 07/08/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/08/2024) (4) |
| Jul 8, 2024 | 239 | STIPULATION AND ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A PROPOSED ORDER ESTABLISHING SECURITY UNDER FED. R. CIV. P. 65(c). Signed by Chief District Judge Thomas S. Kleeh on 07/08/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/08/2024) (4) |
| Jul 8, 2024 | 240 | ***SEALED*** SEALED ORDER DENYING REGENERON'S MOTION 199 TO COMPEL. Signed by Magistrate Judge James P. Mazzone on 07/08/2024. (Copy to counsel for Regeneron and Amgen only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) Modified to add order title on 7/8/2024 (snc). (Entered: 07/08/2024) (0) |
| Jul 8, 2024 | 241 | NOTICE OF APPEAL as to (188 in 1:23-cv-00089-TSK-JPM, 215 in 1:24-md-03103-TSK-JPM) Order on Motion to Seal, Sealed Motion by Celltrion, Inc. Filing fee $; 605, receipt number WVNDC-3972083. (Gottlieb, Max) (Entered: 07/08/2024) (3) |
| Jul 8, 2024 | 242 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 241 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(snc) (Additional attachment(s) added on 7/8/2024: # 4 Sealed Order) (snc). (Entered: 07/08/2024) () (1) |
| Jul 8, 2024 | 243 | MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 07/08/2024) () (3) |
| Jul 8, 2024 | 246 | Proposed Order for Injunctive Relief Against Celltrion by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Pogue, David) (Entered: 07/08/2024) (5) |
| Jul 8, 2024 | 243 | MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 07/08/2024) (Attachment Memorandum in Support of Motion to Seal) (4) |
| Jul 8, 2024 | 242 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 241 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(snc) (Additional attachment(s) added on 7/8/2024: # 4 Sealed Order) (snc). (Entered: 07/08/2024) (Attorney List) (24) |
| Jul 8, 2024 | 242 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 241 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(snc) (Additional attachment(s) added on 7/8/2024: # 4 Sealed Order) (snc). (Entered: 07/08/2024) (Docket Sheet) (30) |
| Jul 8, 2024 | 242 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 241 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(snc) (Additional attachment(s) added on 7/8/2024: # 4 Sealed Order) (snc). (Entered: 07/08/2024) (Notice of Appeal) (3) |
| Jul 5, 2024 | 233 | STIPULATION REGARDING RELATED MATTERS by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK(Pogue, David) (Entered: 07/05/2024) (7) |
| Jul 5, 2024 | 234 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Pogue, David) (Entered: 07/05/2024) () (4) |
| Jul 5, 2024 | 234 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Pogue, David) (Entered: 07/05/2024) (Attachment Memorandum in Support) (6) |
| Jul 5, 2024 | 234 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Pogue, David) (Entered: 07/05/2024) (Proposed Order) (1) |
| Jul 3, 2024 | 225 | STIPULATION AND [PROPOSED] ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A JOINT PROPOSED REDACTED VERSION OF THE COURT'S ORDER GRANTING MOTION FOR PRELIMINARY INJUNCTION by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 07/03/2024) (5) |
| Jul 3, 2024 | 226 | REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) () (5) |
| Jul 3, 2024 | 227 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memorandum In Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/03/2024) () (3) |
| Jul 3, 2024 | 228 | STIPULATION AND [PROPOSED] ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A PROPOSED ORDER ESTABLISHING SECURITY UNDER FED. R. CIV. P. 65(c) by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 07/03/2024) (5) |
| Jul 3, 2024 | 229 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 07/03/2024) () (4) |
| Jul 3, 2024 | 229 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 07/03/2024) (Attachment Memorandum in Support) (6) |
| Jul 3, 2024 | 229 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 07/03/2024) (Proposed Order) (1) |
| Jul 3, 2024 | 227 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memorandum In Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/03/2024) (Attachment Memorandum In Support) (3) |
| Jul 3, 2024 | 227 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memorandum In Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/03/2024) (Proposed Order) (1) |
| Jul 3, 2024 | 226 | REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 1) (3) |
| Jul 3, 2024 | 226 | REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 2) (2) |
| Jul 3, 2024 | 226 | REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 3) (3) |
| Jul 3, 2024 | 226 | REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 4) (2) |
| Jul 3, 2024 | 226 | REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 5) (4) |
| Jul 3, 2024 | 226 | REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 6) (2) |
| Jul 3, 2024 | 226 | REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 7) (2) |
| Jul 2, 2024 | 223 | ***SEALED***ORDER ESTABLISHING SECURITY UNDER FEDERAL RULE OF CIVIL PROCEDURE 65(c). Signed by Chief District Judge Thomas S. Kleeh on 07/02/2024. (Copy to counsel for Regeneron and Samsung only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 07/02/2024) (0) |
| Jul 2, 2024 | 224 | *SEALED* TRANSCRIPT of Sealed Hearing held on 7/1/2024, before Judge Mazzone. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968.. (ck) (Entered: 07/02/2024) (0) |
| Jul 1, 2024 | 220 | ORDER GRANTING MOTION 217 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 7/1/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM. (jb) (Copy to counsel) (Entered: 07/01/2024) (1) |
| Jun 28, 2024 | 215 | ***SEALED***ORDER GRANTING MOTION FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 06/28/2024. (Copy to counsel for Regeneron and Celltrion only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 06/28/2024) (0) |
| Jun 28, 2024 | 216 | ORDER ON MOTION of USCA for the FEDERAL CIRCUIT as to 801 in 1:22-cv-00061-TSK-JPM and 190 in 1:24-md-03103-TSK-JPM Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. (snc) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | 217 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/28/2024) () (2) |
| Jun 28, 2024 | 219 | Proposed Order for Injunctive Relief Against Formycon by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/28/2024) (4) |
| Jun 28, 2024 | 222 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG. USCA for the Federal Circuit USCA Case Number: 2024-2019. Case Manager: M. Ames. (Clerk confirmed with Federal Circuit (J. Phillips) that this second appeal was opened in error and that a termination letter would be issued.) (dk) (Entered: 07/01/2024) (4) |
| Jun 28, 2024 | 217 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/28/2024) (Attachment Memo) (2) |
| Jun 28, 2024 | 217 | MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/28/2024) (Proposed Order) (1) |
| Jun 26, 2024 | 211 | ***SEALED***SEALED ORDER SETTING DEADLINES AND ORAL ARGUMENT/EVIDENTIARY HEARING. Signed by Magistrate Judge James P. Mazzone on 06/26/2024. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/26/2024) (0) |
| Jun 26, 2024 | 212 | STIPULATION AND ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A PROPOSED ORDER ESTABLISHING SECURITY UNDER FED. R. CIV. P. 65(c). Signed by Chief District Judge Thomas S. Kleeh on 06/26/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/26/2024) (5) |
| Jun 26, 2024 | 213 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re 242 in 1:23-cv-00097-TSK-JPM and 203 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Formycon AG. Federal Circuit USCA Case Number: 2024-2009. (snc) (Entered: 06/26/2024) (4) |
| Jun 26, 2024 | 214 | RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) () (8) |
| Jun 26, 2024 | 214 | RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 1) (5) |
| Jun 26, 2024 | 214 | RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 2) (7) |
| Jun 26, 2024 | 214 | RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 3) (6) |
| Jun 26, 2024 | 214 | RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 4) (3) |
| Jun 26, 2024 | 214 | RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 5) (4) |
| Jun 26, 2024 | 214 | RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Proposed Order) (4) |
| Jun 25, 2024 | 203 | NOTICE OF APPEAL as to (241 in 1:23-cv-00097-TSK-JPM, 193 in 1:24-md-03103-TSK-JPM) Order on Motion to Seal, Sealed Motion, by Formycon AG. Filing fee $; 605, receipt number WVNDC-3965824. (Griffith, M.) Modified to add link on 6/25/2024 (dk). (Entered: 06/25/2024) (3) |
| Jun 25, 2024 | 204 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 203 ( 242 in 1:23-cv-00097-TSK-JPM) Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Additional attachment(s) added on 6/25/2024: # 4 Sealed Order) (snc). (Main Document 204 replaced on 7/12/2024) (snc). (Entered: 06/25/2024) () (1) |
| Jun 25, 2024 | 205 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re 801 in 1:22-cv-00061-TSK-JPM and 190 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. Federal Circuit USCA Case Number: 2024-2002. (snc) (Entered: 06/25/2024) (4) |
| Jun 25, 2024 | 206 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 198 ). Signed by Chief District Judge Thomas S. Kleeh on 06/25/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/25/2024) (1) |
| Jun 25, 2024 | 207 | ORDER OF REFERRAL. The motion 199 is REFERRED to Magistrate Judge James P. Mazzone for disposition. Signed by Chief District Judge Thomas S. Kleeh on 06/25/2024. (Copy to MJ Mazzone) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/25/2024) (1) |
| Jun 25, 2024 | 208 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 200 ). Signed by Chief District Judge Thomas S. Kleeh on 06/25/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 06/25/2024) (1) |
| Jun 25, 2024 | 209 | STIPULATION AND ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A PROPOSED ORDER ESTABLISHING SECURITY UNDER FED.R. CIV.P. 65(c). IT IS THEREFORE STIPULATED AND AGREED, that the parties' deadline to submit a Proposed Rule 65(c) Security Order(s) is extended to July l, 2024. Signed by Chief District Judge Thomas S. Kleeh on 06/25/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 06/25/2024) (4) |
| Jun 25, 2024 | 210 | STIPULATION AND [PROPOSED] ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A PROPOSED ORDER ESTABLISHING SECURITY UNDER FED. R. CIV. P. 65(c) by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 06/25/2024) (6) |
| Jun 25, 2024 | 204 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 203 ( 242 in 1:23-cv-00097-TSK-JPM) Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Additional attachment(s) added on 6/25/2024: # 4 Sealed Order) (snc). (Main Document 204 replaced on 7/12/2024) (snc). (Entered: 06/25/2024) (Attorney List) (30) |
| Jun 25, 2024 | 204 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 203 ( 242 in 1:23-cv-00097-TSK-JPM) Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Additional attachment(s) added on 6/25/2024: # 4 Sealed Order) (snc). (Main Document 204 replaced on 7/12/2024) (snc). (Entered: 06/25/2024) (Docket Sheet) (30) |
| Jun 25, 2024 | 204 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 203 ( 242 in 1:23-cv-00097-TSK-JPM) Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Additional attachment(s) added on 6/25/2024: # 4 Sealed Order) (snc). (Main Document 204 replaced on 7/12/2024) (snc). (Entered: 06/25/2024) (Notice of Appeal) (3) |
| Jun 24, 2024 | 194 | Redacted Order Granting Motions for Preliminary Injunction. Signed by Chief District Judge Thomas S. Kleeh on 06/14/2024. (Filed as public Order per Chambers (rr)) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 06/24/2024) (30) |
| Jun 24, 2024 | 195 | ***SEALED***ORDER. Signed by Magistrate Judge James P. Mazzone on 06/24/2024. (Copy to counsel of record only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/24/2024) (0) |
| Jun 24, 2024 | 198 | MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) () (4) |
| Jun 24, 2024 | 200 | MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) () (4) |
| Jun 24, 2024 | 202 | STIPULATION AND [PROPOSED] ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A PROPOSED ORDER ESTABLISHING SECURITY UNDER FED. R. CIV. P. 65(c) by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) (5) |
| Jun 24, 2024 | 198 | MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) (Memorandum of Law in Support) (6) |
| Jun 24, 2024 | 198 | MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) (Proposed Order) (1) |
| Jun 24, 2024 | 200 | MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) (Memorandum of Law in Support) (6) |
| Jun 24, 2024 | 200 | MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) (Proposed Order) (1) |
| Jun 21, 2024 | 188 | Redacted Order Granting Motion for Permanent Injunction. Signed by Chief District Judge Thomas S. Kleeh on 06/11/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (Filed as public order per Chambers (rr)) (snc) (Entered: 06/21/2024) (30) |
| Jun 21, 2024 | 189 | ORDER FOR INJUNCTIVE RELIEF AGAINST BIOCON AND MYLAN. Signed by Chief District Judge Thomas S. Kleeh on 06/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/21/2024) (3) |
| Jun 21, 2024 | 190 | NOTICE OF APPEAL by Mylan Pharmaceuticals Inc., BIOCON BIOLOGICS INC.. Filing fee $; 605, receipt number WVNDC-3963945. Appeal Record due by 7/21/2025. (Copland, Gordon) (Entered: 06/21/2024) (4) |
| Jun 21, 2024 | 191 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 190 in 1:24-md-03103-TSK-JPM and 801 in 1:22-cv-00061-TSK-JPM Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Judgment) Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/21/2024) () (1) |
| Jun 21, 2024 | 192 | ORDER OVERRULING OBJECTIONS TO MAGISTRATE JUDGE'S ORDER. Signed by Chief District Judge Thomas S Kleeh on 06/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/21/2024) (2) |
| Jun 21, 2024 | 193 | ***SEALED*** ORDER GRANTING MOTION FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 06/21/2024. (Copy to counsel for Regeneron and Formycon only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/21/2024) (0) |
| Jun 21, 2024 | 191 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 190 in 1:24-md-03103-TSK-JPM and 801 in 1:22-cv-00061-TSK-JPM Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Judgment) Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/21/2024) (Attorney List) (24) |
| Jun 21, 2024 | 191 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 190 in 1:24-md-03103-TSK-JPM and 801 in 1:22-cv-00061-TSK-JPM Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Judgment) Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/21/2024) (Docket Sheet) (30) |
| Jun 21, 2024 | 191 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 190 in 1:24-md-03103-TSK-JPM and 801 in 1:22-cv-00061-TSK-JPM Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Judgment) Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/21/2024) (Notice of Appeal) (4) |
| Jun 21, 2024 | 191 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 190 in 1:24-md-03103-TSK-JPM and 801 in 1:22-cv-00061-TSK-JPM Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Judgment) Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/21/2024) (Judgment) (1) |
| Jun 20, 2024 | 182 | MOTION to Withdraw (Jeffrey A. Marx) by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 06/20/2024) () (3) |
| Jun 20, 2024 | 183 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re 244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD. Federal Circuit USCA Case Number: 2024-1966. (snc) (Entered: 06/20/2024) (4) |
| Jun 20, 2024 | 184 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re 176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM. Notice of Appeal filed by Samsung Bioepis Co., Ltd. Federal Circuit USCA Case Number: 2024-1965. (snc) (Entered: 06/20/2024) (4) |
| Jun 20, 2024 | 185 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 180 ). Signed by Chief District Judge Thomas S. Kleeh on 06/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 06/20/2024) (1) |
| Jun 20, 2024 | 186 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL: granting 206 motion in 1:23-cv-97. Signed by Chief District Judge Thomas S. Kleeh on 06/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/20/2024) (1) |
| Jun 20, 2024 | 187 | ORDER GRANTING MOTION TO WITHDRAW. ( 797 in 1:22-cv-00061-TSK-JPM, 182 in 1:24-md-03103-TSK-JPM). Signed by Chief District Judge Thomas S. Kleeh on 06/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/20/2024) (1) |
| Jun 20, 2024 | 182 | MOTION to Withdraw (Jeffrey A. Marx) by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(O'Brien, William) (Entered: 06/20/2024) (Proposed Order) (1) |
| Jun 19, 2024 | 180 | MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 06/19/2024) () (3) |
| Jun 19, 2024 | 180 | MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 06/19/2024) (Attachment Memorandum in Support of Motion to Seal) (4) |
| Jun 17, 2024 | 177 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 175 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal )Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) (Additional attachment(s) added on 6/17/2024: # 4 Sealed Order) (snc). (Entered: 06/17/2024) () (1) |
| Jun 17, 2024 | 178 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 176 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Additional attachment(s) added on 6/17/2024: # 4 Sealed Order) (snc). (Entered: 06/17/2024) () (1) |
| Jun 17, 2024 | 179 | NOTICE of Appearance by Ryan Moore on behalf of Amgen, Inc., Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Moore, Ryan) (Entered: 06/17/2024) (1) |
| Jun 17, 2024 | 178 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 176 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Additional attachment(s) added on 6/17/2024: # 4 Sealed Order) (snc). (Entered: 06/17/2024) (Attorney List) (23) |
| Jun 17, 2024 | 178 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 176 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Additional attachment(s) added on 6/17/2024: # 4 Sealed Order) (snc). (Entered: 06/17/2024) (Docket Sheet) (30) |
| Jun 17, 2024 | 178 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 176 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Additional attachment(s) added on 6/17/2024: # 4 Sealed Order) (snc). (Entered: 06/17/2024) (Notice of Appeal) (3) |
| Jun 17, 2024 | 177 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 175 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal )Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) (Additional attachment(s) added on 6/17/2024: # 4 Sealed Order) (snc). (Entered: 06/17/2024) (Attorney List) (23) |
| Jun 17, 2024 | 177 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 175 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal )Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) (Additional attachment(s) added on 6/17/2024: # 4 Sealed Order) (snc). (Entered: 06/17/2024) (Docket Sheet) (30) |
| Jun 17, 2024 | 177 | Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 175 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal )Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (snc) (Additional attachment(s) added on 6/17/2024: # 4 Sealed Order) (snc). (Entered: 06/17/2024) (Notice of Appeal) (3) |
| Jun 14, 2024 | 168 | ORDER DENYING MOTIONS TO STRIKE RELATING TO THE ATWAL DECLARATION (ECF NOS. 168 , 171 . Signed by Chief District Judge Thomas S. Kleeh on 06/14/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 06/14/2024) (5) |
| Jun 14, 2024 | 169 | ***SEALED*** ORDER GRANTING MOTION FOR CLARIFICATION (ECF NO. 135 ). Signed by Chief District Judge Thomas S. Kleeh on 06/14/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (Copy to counsel for Regeneron, Formycon and Samsung) (snc) (Entered: 06/14/2024) (0) |
| Jun 14, 2024 | 170 | ORDER DENYING EMERGENCY MOTION TO STRIKE RELATING TO GRAHAM DECLARATION (ECF NO. [195-2]. Signed by Chief District Judge Thomas S. Kleeh on 06/14/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 06/14/2024) (4) |
| Jun 14, 2024 | 171 | ***SEALED*** ORDER GRANTING MOTIONS FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 06/14/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (Copy ONLY to counsel for Regeneron and Samsung) (snc) (Entered: 06/14/2024) (0) |
| Jun 14, 2024 | 172 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. Notice of Deposition of Sean Sheridan. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/14/2024) (1) |
| Jun 14, 2024 | 173 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. Notice of Deposition of Kevin Clark. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/14/2024) (1) |
| Jun 14, 2024 | 174 | CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. Notice of Deposition of Bernhardt Trout. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/14/2024) (1) |
| Jun 14, 2024 | 175 | NOTICE OF APPEAL re 171 . Associated Cases 1:24md-03103-TSK-JPM; DN 223 in 1:23-cv-00094 (Order on Motion to Seal,, Order on Motion for Leave to File (Sealed)) by Samsung Bioepis, CO., LTD. Filing fee $; 605, receipt number WVNDC-3961009. Appeal Record due by 7/15/2024. (Law, Sandra) Modified to add related linkage on 6/17/2024 (dk). (Entered: 06/14/2024) (3) |
| Jun 14, 2024 | 176 | NOTICE OF APPEAL re 171 . Associated Cases 1:24md-03103-TSK-JPM; DN 225 in 1:23-cv-00106 (Order on Motion to Seal, Order on Motion for Leave to File (Sealed) Order on Motion to Seal, Order on Motion for Leave to File (Sealed)) by Samsung Bioepis Co., Ltd. Filing fee $; 605, receipt number WVNDC-3961010. Appeal Record due by 7/15/2024. (Law, Sandra) Modified to add related linkage on 6/17/2024 (dk). (Entered: 06/14/2024) (3) |
| Jun 13, 2024 | 166 | Withdrawal of Amgen Inc.'s Motion to Compel Other Document re (125 in 1:24-cv-00039-TSK-JPM) MOTION to Compel filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/13/2024) () (4) |
| Jun 13, 2024 | 167 | ORDER DENYING AS MOOT AMGEN INC.'S MOTION TO COMPEL. In light of Amgen Inc's withdrawal of its Motion to Compel, the Motion (ECF Nos. 21 and 125 is DENIED AS MOOT. The hearing currently set for June 20, 2024, is CANCELLED. Signed by Magistrate Judge James P. Mazzone on 06/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/13/2024) (1) |
| Jun 13, 2024 | 166 | Withdrawal of Amgen Inc.'s Motion to Compel Other Document re (125 in 1:24-cv-00039-TSK-JPM) MOTION to Compel filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/13/2024) (Exhibit 1) (4) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) () (4) |
| Jun 12, 2024 | 165 | CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Second Requests for Production of Documents and Things to Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 06/12/2024) (1) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Supplement Memo ISO) (8) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Proposed Order) (3) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 1) (2) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 2) (5) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 3) (9) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 4) (13) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 5) (3) |
| Jun 12, 2024 | 164 | MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 6) (5) |
| Jun 11, 2024 | 160 | ORDER SETTING DEADLINES AND ORAL ARGUMENT/EVIDENTIARY HEARING re 21 Motion to Compel. (Responses due by 6/14/2024, Replies due by 6/18/2024., Oral Argument/Evidentiary Hearing set for 6/20/2024 at 10:00 AM in Wheeling Magistrate Judge Courtroom, 4th Floor before Magistrate Judge James P. Mazzone.) Signed by Magistrate Judge James P. Mazzone on 06/11/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/11/2024) (1) |
| Jun 11, 2024 | 161 | ORDER OVERRULING OBJECTIONS TO MAGISTRATE JUDGE'S ORDER. The motion 126 for an extension is GRANTED, and Defendants' response 143 is deemed FILED. Regeneron's motion 153 for leave to file a reply is DENIED. Regeneron's objections 62 to the Magistrate Judge's order are OVERRULED. Signed by Chief District Judge Thomas S. Kleeh on 06/11/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/11/2024) (4) |
| Jun 11, 2024 | 162 | ***SEALED***ORDER GRANTING MOTION FOR PERMANENT INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 06/11/2024. (Copy to counsel for Regeneron, Mylan and Biocon ONLY) Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/11/2024) (0) |
| Jun 11, 2024 | 163 | CLERK'S JUDGMENT. Signed by Clerk of Court on 06/11/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 06/11/2024) (1) |
| Jun 10, 2024 | 158 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 156 ). Signed by Chief District Judge Thomas S. Kleeh on 06/10/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 06/10/2024) (1) |
| Jun 10, 2024 | 159 | ORDER OF REFERRAL. The motion 21 is REFERRED to Magistrate Judge James P. Mazzone for disposition. Signed by Chief District Judge Thomas S. Kleeh on 06/10/2024. (Copy to MJ Mazzone) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 06/10/2024) (1) |
| Jun 7, 2024 | 156 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 06/07/2024) () (4) |
| Jun 7, 2024 | 156 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 06/07/2024) (Attachment Memorandum in Support) (6) |
| Jun 7, 2024 | 156 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 06/07/2024) (Proposed Order) (1) |
| Jun 5, 2024 | 155 | Memorandum in Opposition re (790 in 1:22-cv-00061-TSK-JPM) MOTION for Leave to File Reply in Support of Regeneron's Objections to Magistrate Judge's Order [Defendants Opposition to Regenerons Motion for Leave to File a Reply in Support Of Regenerons Objections to The March 26, 2024 Sanctions Order] filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit Exhibit 1)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 06/05/2024) () (13) |
| Jun 5, 2024 | 155 | Memorandum in Opposition re (790 in 1:22-cv-00061-TSK-JPM) MOTION for Leave to File Reply in Support of Regeneron's Objections to Magistrate Judge's Order [Defendants Opposition to Regenerons Motion for Leave to File a Reply in Support Of Regenerons Objections to The March 26, 2024 Sanctions Order] filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit Exhibit 1)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 06/05/2024) (Exhibit Exhibit 1) (6) |
| May 31, 2024 | 153 | MOTION for Leave to File Reply in Support of Regeneron's Objections to Magistrate Judge's Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Regeneron's Reply in Support of Its Objections to the Magistrate Judge's Order Granting Defendants' Motion for Sanctions)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/31/2024) () (5) |
| May 31, 2024 | 154 | Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) () (14) |
| May 31, 2024 | 153 | MOTION for Leave to File Reply in Support of Regeneron's Objections to Magistrate Judge's Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Regeneron's Reply in Support of Its Objections to the Magistrate Judge's Order Granting Defendants' Motion for Sanctions)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/31/2024) (Attachment Regeneron's Reply in Support of Its Objections to the Magistrate) (16) |
| May 31, 2024 | 154 | Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix A - Regeneron's Filings) (30) |
| May 31, 2024 | 154 | Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix B - Amgen's Filings) (30) |
| May 31, 2024 | 154 | Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix C - Mylan/Biocon's Filings) (30) |
| May 31, 2024 | 154 | Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis) (30) |
| May 30, 2024 | 151 | ORDER EXTENDING TEMPORARY RESTRAINING ORDER: granting 788 and 150 Motions. Signed by Chief District Judge Thomas S. Kleeh on 05/30/2024. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM (snc) (Entered: 05/30/2024) (3) |
| May 30, 2024 | 152 | ORDER EXTENDING TEMPORARY RESTRAINING ORDER: granting 236 , 218 and 149 Motions. Signed by Chief District Judge Thomas S. Kleeh on 05/30/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 05/30/2024) (3) |
| May 29, 2024 | 147 | STIPULATION and Joint Request for Entry of Agreed Protective Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order Stipulated Protective Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Pogue, David) (Entered: 05/29/2024) () (4) |
| May 29, 2024 | 148 | STIPULATED PROTECTIVE ORDER. Signed by Chief District Judge Thomas S. Kleeh on 05/29/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/29/2024) (30) |
| May 29, 2024 | 149 | MOTION for Extension of Temporary Restraining Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 05/29/2024) () (5) |
| May 29, 2024 | 150 | MOTION for Extension of Temporary Restraining Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/29/2024) () (6) |
| May 29, 2024 | 147 | STIPULATION and Joint Request for Entry of Agreed Protective Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order Stipulated Protective Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Pogue, David) (Entered: 05/29/2024) (Proposed Order Stipulated Protective Order) (30) |
| May 29, 2024 | 150 | MOTION for Extension of Temporary Restraining Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/29/2024) (Proposed Order) (3) |
| May 29, 2024 | 149 | MOTION for Extension of Temporary Restraining Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 05/29/2024) (Proposed Order) (3) |
| May 28, 2024 | 144 | ORDER. Regeneron's Motion to Partially Withdraw Motions for Preliminary Injunction is GRANTED 119 . The portions of Regeneron's preliminary injunction motions that do not relate to the 865 patent are hereby WITHDRAWN. Amgen's motion for clarification on this issue is GRANTED 142 . The Court AMENDS the preliminary injunction briefing schedule with respect to Amgen. Signed by Chief District Judge Thomas S. Kleeh on 05/28/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) (Entered: 05/28/2024) (2) |
| May 28, 2024 | 145 | ORDER GRANTING MOTION TO WITHDRAW. The Court GRANTS the motion 127 and DIRECTS the Clerk to terminate Attorney Abraham Varon from the list of attorneys in this case. Signed by Chief District Judge Thomas S. Kleeh on 05/28/2024. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(snc) (Entered: 05/28/2024) (1) |
| May 28, 2024 | 146 | STIPULATION AND ORDER TO SUPPLEMENT PRELIMINARY INJUNCTION RECORD. Signed by Chief District Judge Thomas S. Kleeh on 05/28/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 05/28/2024) (13) |
| May 24, 2024 | 136 | ORDER SETTING BRIEFING SCHEDULE WITH RESPECT TO ANY MOTION FOR PRELIMINARY INJUNCTION AGAINST AMGEN. Motion, on or before June 7, 2024; Response, on or before June 21, 2024; Reply, on or before July 3, 2024. Signed by Chief District Judge Thomas S. Kleeh on 05/24/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/24/2024) (1) |
| May 24, 2024 | 137 | STIPULATION and proposed Order to Supplement Preliminary Injunction Record by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/24/2024) (5) |
| May 24, 2024 | 138 | STIPULATION and proposed Order to Supplement Preliminary Injunction Record (corrected to include Exhibit A) by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. (Attachments: # 1 Exhibit A)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/24/2024) () (5) |
| May 24, 2024 | 139 | Pro Hac Vice Filing fee: $ 600.00, receipt number 100003909. (For Damron, Carey and Franks) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/24/2024) (0) |
| May 24, 2024 | 140 | Pro Hac Vice Filing fee: $ 400.00, receipt number 100003910. (For Attorneys Damron and Carey) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00053-TSK (snc) (Entered: 05/24/2024) (0) |
| May 24, 2024 | 141 | RESPONSE to Motion re (232 in 1:23-cv-00097-TSK-JPM) MOTION to Withdraw Motion to Partially Withdraw Motions for Preliminary Injunction filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 05/24/2024) (4) |
| May 24, 2024 | 142 | Emergency MOTION to Clarify Whether Regeneron's Preliminary Injunction Motion Will Be Limited to the '865 Patent by Amgen, Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/24/2024) (4) |
| May 24, 2024 | 143 | RESPONSE by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 05/24/2024) (30) |
| May 24, 2024 | 138 | STIPULATION and proposed Order to Supplement Preliminary Injunction Record (corrected to include Exhibit A) by Samsung Bioepis, CO., LTD.,, Samsung Bioepis Co., Ltd.. (Attachments: # 1 Exhibit A)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/24/2024) (Exhibit A) (8) |
| May 23, 2024 | 128 | RESPONSE to Motion re (783 in 1:22-cv-00061-TSK-JPM) MOTION for Extension of Time to File Response To Regenerons Objections To The Magistrate Judges Order Granting Defendants Motion For Sanctions filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/23/2024) () (4) |
| May 23, 2024 | 129 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Jordan L. Damron Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/23/2024) (1) |
| May 23, 2024 | 130 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Michael W. Carey Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/23/2024) (1) |
| May 23, 2024 | 131 | Pro Hac Vice Filing fee: $ 400.00, receipt number 100003908. (For Attorneys E. Weiswasser and A. Goldsmith) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/23/2024) (0) |
| May 23, 2024 | 132 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Raymond S. Franks II Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/23/2024) (1) |
| May 23, 2024 | 133 | NOTICE by Regeneron Pharmaceuticals, Inc. Notice of Appearance of Jordan L. Damron Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00053-TSK(Ruby, Steven) (Entered: 05/23/2024) (1) |
| May 23, 2024 | 134 | NOTICE by Regeneron Pharmaceuticals, Inc. Notice of Appearance of Michael W. Carey Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00053-TSK(Ruby, Steven) (Entered: 05/23/2024) (1) |
| May 23, 2024 | 135 | Pro Hac Vice Filing fee: $ 800.00, receipt number 100003907. (For Attorneys A. Picard, R. Krawetz, G. Knofczynski and V. Van Beck) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00053-TSK (snc) (Entered: 05/23/2024) (0) |
| May 23, 2024 | 128 | RESPONSE to Motion re (783 in 1:22-cv-00061-TSK-JPM) MOTION for Extension of Time to File Response To Regenerons Objections To The Magistrate Judges Order Granting Defendants Motion For Sanctions filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/23/2024) (Exhibit 1) (4) |
| May 23, 2024 | 128 | RESPONSE to Motion re (783 in 1:22-cv-00061-TSK-JPM) MOTION for Extension of Time to File Response To Regenerons Objections To The Magistrate Judges Order Granting Defendants Motion For Sanctions filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/23/2024) (Exhibit 2) (28) |
| May 22, 2024 | 120 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Elizabeth S. Weiswasser Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/22/2024) (1) |
| May 22, 2024 | 121 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Andrew E. Goldsmith Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/22/2024) (1) |
| May 22, 2024 | 122 | NOTICE by Regeneron Pharmaceuticals, Inc. Notice of Appearance of Alyssa J. Picard Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00053-TSK(Ruby, Steven) (Entered: 05/22/2024) (1) |
| May 22, 2024 | 123 | NOTICE by Regeneron Pharmaceuticals, Inc. Notice of Appearance of Rhochelle Krawetz Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00053-TSK(Ruby, Steven) (Entered: 05/22/2024) (1) |
| May 22, 2024 | 124 | NOTICE by Regeneron Pharmaceuticals, Inc. Notice of Appearance of Grace W. Knofczynski Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00053-TSK(Ruby, Steven) (Entered: 05/22/2024) (1) |
| May 22, 2024 | 125 | NOTICE by Regeneron Pharmaceuticals, Inc. Notice of Appearance of Kellie C. Van Beck Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00053-TSK(Ruby, Steven) (Entered: 05/22/2024) (1) |
| May 22, 2024 | 126 | MOTION for Extension of Time to File Response To Regenerons Objections To The Magistrate Judges Order Granting Defendants Motion For Sanctions by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 05/22/2024) () (4) |
| May 22, 2024 | 127 | MOTION to Withdraw as Attorney on behalf of Abraham Varon by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 05/22/2024) () (3) |
| May 22, 2024 | 126 | MOTION for Extension of Time to File Response To Regenerons Objections To The Magistrate Judges Order Granting Defendants Motion For Sanctions by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 05/22/2024) (Proposed Order) (1) |
| May 22, 2024 | 127 | MOTION to Withdraw as Attorney on behalf of Abraham Varon by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 05/22/2024) (Proposed Order) (1) |
| May 21, 2024 | 115 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 22 , 100 , 101 . Signed by Chief District Judge Thomas S. Kleeh on 05/21/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM, 1:24-cv-00039-TSK (snc) (Entered: 05/21/2024) (1) |
| May 21, 2024 | 116 | ORDER REGARDING LIAISON COUNSEL. Signed by Chief District Judge Thomas S. Kleeh on 05/21/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) (Entered: 05/21/2024) (2) |
| May 21, 2024 | 117 | MEMBER CASE OPENED: Case opened re NDWV No. 1:24-cv-53, Regeneron v. Celltrion (Complaint). The following orders have been filed in 1:24-cv-53: 24 Pretrial Order #1. (Copy to JPML) (snc) (Entered: 05/21/2024) (0) |
| May 21, 2024 | 118 | ORDER DENYING CERTAIN MOTIONS AS MOOT. Regeneron's motion for guidance 36 and Amgen's motion requesting an expedited status conference 20 are DENIED AS MOOT. Signed by Chief District Judge Thomas S. Kleeh on 05/21/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) Modified to unseal on 5/21/2024; Order was sealed in error. NEF regen. (dk). (Entered: 05/21/2024) (1) |
| May 21, 2024 | 119 | MOTION to Withdraw Motion to Partially Withdraw Motions for Preliminary Injunction by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 05/21/2024) (4) |
| May 20, 2024 | 112 | ORDER. The parties are DIRECTED to file, on or before May 31, 2024, written proposals indicating which matters are appropriate for collective pretrial consideration and disposition while the case is designated as an MDL. Signed by Chief District Judge Thomas S. Kleeh on 5/20/2024. Associated Cases: 1:24-md-03103-TSK et al. (jb) (Entered: 05/20/2024) (1) |
| May 20, 2024 | 113 | MOTION to Withdraw Appearance of Siegmund Gutman by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/20/2024) () (3) |
| May 20, 2024 | 114 | ORDER GRANTING AMGEN INC.'S 113 and 161 MOTION FOR WITHDRAWAL OF APPEARANCE AND TERMINATION OF CM/ECF RECORD OF SIEGMUND GUTMAN. Siegmund Gutman terminated from 1:24-md-3103 and 1:24-cv-39. Signed by Chief District Judge Thomas S. Kleeh on 5/20/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (jb) (Entered: 05/20/2024) (1) |
| May 20, 2024 | 113 | MOTION to Withdraw Appearance of Siegmund Gutman by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/20/2024) (Proposed Order) (2) |
| May 17, 2024 | 107 | ORDER GRANTING MOTION FOR TEMPORARY RESTRAINING ORDER (ECF NO. 70 ). Signed by Chief District Judge Thomas S. Kleeh on 05/17/2024. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM (snc) (Entered: 05/17/2024) (4) |
| May 17, 2024 | 108 | ORDER GRANTING MOTION FOR TEMPORARY RESTRAINING ORDER (ECF NO. 72 ). Signed by Chief District Judge Thomas S. Kleeh on 05/17/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 05/17/2024) (4) |
| May 17, 2024 | 109 | ORDER GRANTING 104 MOTION TO SEAL. Signed by Chief District Judge Thomas S. Kleeh on 05/17/2024. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM (snc) (Entered: 05/17/2024) (2) |
| May 17, 2024 | 110 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh, Scheduling Conference held on 5/17/2024. (Court Reporter Cindy Knecht) Associated Cases: 1:24-md-03103-TSK et al. (dk) (Entered: 05/17/2024) (0) |
| May 17, 2024 | 111 | TRANSCRIPT of status conference held on 5/17/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 6/7/2024. Redacted Transcript Deadline set for 6/17/2024. Release of Transcript Restriction set for 8/15/2024. Associated Cases: 1:24-md-03103-TSK et al.(ck) (Entered: 05/17/2024) (22) |
| May 16, 2024 | 78 | ORDER GRANTING MOTION TO WITHDRAW APPEARANCES (ECF 181 , 163 ). The Clerk is DIRECTED to terminate J. Brett Milbourn and Joe Kronawitter of the law firm Horn Aylward & Bandy, LLC as limited appearance counsel for Plaintiff. Signed by Chief District Judge Thomas S Kleeh on 5/16/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(dk) (Entered: 05/16/2024) (2) |
| May 16, 2024 | 79 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Mary Charlotte Y. Carroll Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 80 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Jennifer Melien Brooks Crozier Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 81 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Anish Desai Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 82 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Teagan J. Gregory Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 83 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Jacob E. Hartman Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 84 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Sven E. Henningson III Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 85 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Natalie C. Kennedy Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 86 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Grace W. Knofczynski Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 87 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Rhochelle Krawetz Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 88 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Kathryn Leicht Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 89 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Zhen Lin Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 90 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Shaun P. Mahaffy Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 91 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Priyata Patel Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 92 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Christopher Pepe Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 93 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Alyssa J. Picard Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 94 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Rocco Recce Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 95 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Matthew D. Sieger Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 96 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Kellie C. Van Beck Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 97 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Tom Yu Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 98 | NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Yi Zhang Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1) |
| May 16, 2024 | 99 | Pro Hac Vice Filing fee: $ 4000.00, receipt number 100003903. (For Attorneys Carroll, Crozier, Desai, Gregory, Hartman, Henningson, Kennedy, Knofczynski, Krawetz, Leicht, Lin, Mahaffy, Patel, Pepe, Picard, Recce, Sieger, Van Beck, Yu and Zhang) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/16/2024) (0) |
| May 16, 2024 | 100 | MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM(Law, Sandra) (Entered: 05/16/2024) () (4) |
| May 16, 2024 | 101 | MOTION for Leave to File Under Seal by Samsung Bioepis Co., Ltd.. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/16/2024) () (4) |
| May 16, 2024 | 104 | MOTION for Leave to File UNDER SEAL by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 05/16/2024) () (3) |
| May 16, 2024 | 106 | REDACTION Regeneron's Objections to the Magistrate Judge's Order Granting Defendants' Motion for Sanctions [Dkt. No. 769] by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/16/2024) (30) |
| May 16, 2024 | 101 | MOTION for Leave to File Under Seal by Samsung Bioepis Co., Ltd.. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/16/2024) (Attachment Memorandum in Support of Motion to Seal) (4) |
| May 16, 2024 | 104 | MOTION for Leave to File UNDER SEAL by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 05/16/2024) (Proposed Order) (2) |
| May 16, 2024 | 100 | MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM(Law, Sandra) (Entered: 05/16/2024) (Attachment Memorandum in Support of Motion to Seal) (4) |
| May 15, 2024 | 73 | ORDER GRANTING 71 MOTION FOR LEAVE TO FILE UNDER SEAL. Signed by Chief District Judge Thomas S. Kleeh on 05/15/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 05/15/2024) (2) |
| May 15, 2024 | 74 | ORDER GRANTING CERTAIN MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 42 , 47 , 60 , 63 , 68 , 69 . Signed by Chief District Judge Thomas S. Kleeh on 05/15/2024. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to unseal - NEF regenerated (snc). (Entered: 05/15/2024) (1) |
| May 15, 2024 | 76 | ***SEALED*** STIPULATION OF DEFENDANT CELLTRION, INC. CONCERNING TEMPORARY RESTRAINING ORDER. Signed by Chief District Judge Thomas S. Kleeh on 05/15/2024. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00089-TSK-JPM (snc) (Entered: 05/15/2024) (0) |
| May 15, 2024 | 77 | ***SEALED***AGREED ORDER CONCERNING TEMPORARY RESTRAINING ORDER. Signed by Chief District Judge Thomas S. Kleeh on 05/15/2024. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00097-TSK-JPM (snc) (Entered: 05/15/2024) (0) |
| May 14, 2024 | 65 | ***SEALED*** ORDER GRANTING MOTION TO SEAL (ECF NO. 40 ). Signed by Chief District Judge Thomas S. Kleeh on 05/14/2024. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(snc) (Entered: 05/14/2024) (0) |
| May 14, 2024 | 66 | ORDER GRANTING MOTION FOR LEAVE TO FILE INADVERTENTLY OMITTED EXHIBIT UNDER SEAL. Signed by Chief District Judge Thomas S. Kleeh on 05/14/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(snc) (Entered: 05/14/2024) (2) |
| May 14, 2024 | 67 | Pro Hac Vice Filing fee: $ 2000.00, receipt number 100003902. (For Attorneys A. Pan, A. Trask, A. Argall, D, Berl, E. Oberwetter, H. Anderson, J. Beazley, K. Kayali, R. Griffin, and T. Fletcher) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/14/2024) (0) |
| May 14, 2024 | 69 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/14/2024) () (4) |
| May 14, 2024 | 71 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 05/14/2024) () (5) |
| May 14, 2024 | 71 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 05/14/2024) (Attachment Memorandum in Support) (6) |
| May 14, 2024 | 71 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 05/14/2024) (Proposed Order) (2) |
| May 14, 2024 | 69 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/14/2024) (Attachment Memorandum in Support) (6) |
| May 14, 2024 | 69 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/14/2024) (Proposed Order) (1) |
| May 10, 2024 | 58 | ORDER DENYING MOTION TO EXCEED PAGE LIMIT AND MOTION TO SEAL (ECF NOS. 55 , 56 ). The objections are STRICKEN 57 . Signed by Chief District Judge Thomas S. Kleeh on 05/10/2024. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM (snc) (Entered: 05/10/2024) (1) |
| May 10, 2024 | 59 | Pro Hac Vice Filing fee: $ 200.00, receipt number 100003895. (For Attorney Chanson Chang) (snc) (Entered: 05/10/2024) (0) |
| May 10, 2024 | 60 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support of Motion for Leave to File Under Seal, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/10/2024) () (4) |
| May 10, 2024 | 61 | NOTICE by Regeneron Pharmaceuticals, Inc. Joint Notice of Pending Motions Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/10/2024) (14) |
| May 10, 2024 | 60 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support of Motion for Leave to File Under Seal, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/10/2024) (Memorandum of Law in Support of Motion for Leave to File Under Seal) (6) |
| May 10, 2024 | 60 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support of Motion for Leave to File Under Seal, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/10/2024) (Proposed Order) (2) |
| May 9, 2024 | 53 | ORDER GRANTING INTERVENOR AMGEN'S UNOPPOSED MOTION TO UNSEAL MARCH 26, 2024 ORDER. Signed by Magistrate Judge James P. Mazzone on 05/09/2024. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM (snc) (Entered: 05/09/2024) (1) |
| May 9, 2024 | 54 | NOTICE by Amgen, Inc., Amgen, Inc. of Attorney Appearance of Chanson Chang Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/09/2024) (1) |
| May 9, 2024 | 55 | MOTION to Exceed Page Limit for Objections to Magistrate Judge's Order by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/09/2024) (5) |
| May 9, 2024 | 56 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/09/2024) () (4) |
| May 9, 2024 | 56 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/09/2024) (Attachment Memorandum in Support) (6) |
| May 9, 2024 | 56 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Ruby, Steven) (Entered: 05/09/2024) (Proposed Order) (1) |
| May 8, 2024 | 52 | MOTION to Unseal Document (724 in 1:22-cv-00061-TSK-JPM) MOTION TO ENFORCE THE PROTECTIVE ORDER AND FOR SANCTIONS RELATED TO PLAINTIFF'S PROTECTIVE ORDER VIOLATIONS filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. by AMGEN USA, INC.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Tinney, John) Modified on 5/8/2024 to correct docket entry number (snc). (Entered: 05/08/2024) () (3) |
| May 8, 2024 | 52 | MOTION to Unseal Document (724 in 1:22-cv-00061-TSK-JPM) MOTION TO ENFORCE THE PROTECTIVE ORDER AND FOR SANCTIONS RELATED TO PLAINTIFF'S PROTECTIVE ORDER VIOLATIONS filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. by AMGEN USA, INC.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Tinney, John) Modified on 5/8/2024 to correct docket entry number (snc). (Entered: 05/08/2024) (Proposed Order) (1) |
| May 7, 2024 | 43 | REPLY to Response to Motion re (207 in 1:23-cv-00094-TSK-JPM, 217 in 1:23-cv-00097-TSK-JPM, 168 in 1:23-cv-00089-TSK-JPM, 131 in 1:24-cv-00039-TSK, 754 in 1:22-cv-00061-TSK-JPM, 36 in 1:24-md-03103-TSK, 189 in 1:23-cv-00106-TSK-JPM) MOTION for Guidance Regarding Temporary Restraining Orders in View of the May 18, 2024 Expiration of Regulatory Exclusivity for Eylea filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/07/2024) (4) |
| May 7, 2024 | 45 | MOTION for Leave to File Inadvertently Omitted Exhibit UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 05/07/2024) () (5) |
| May 7, 2024 | 47 | MOTION for Leave to File Inadvertently Omitted Exhibits UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Pogue, David) (Entered: 05/07/2024) () (4) |
| May 7, 2024 | 45 | MOTION for Leave to File Inadvertently Omitted Exhibit UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM(Pogue, David) (Entered: 05/07/2024) (Proposed Order) (2) |
| May 7, 2024 | 47 | MOTION for Leave to File Inadvertently Omitted Exhibits UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM(Pogue, David) (Entered: 05/07/2024) (Proposed Order) (1) |
| May 6, 2024 | 40 | Joint MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/06/2024) () (4) |
| May 6, 2024 | 40 | Joint MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/06/2024) (Attachment Memorandum in Support of Motion to Seal) (4) |
| May 5, 2024 | 38 | RESPONSE to Motion re (207 in 1:23-cv-00094-TSK-JPM, 36 in 1:24-md-03103-TSK) MOTION for Guidance Regarding Temporary Restraining Orders in View of the May 18, 2024 Expiration of Regulatory Exclusivity for Eylea filed by Samsung Bioepis, CO., LTD.,. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM(Law, Sandra) (Entered: 05/05/2024) (7) |
| May 5, 2024 | 39 | RESPONSE to Motion re (36 in 1:24-md-03103-TSK, 189 in 1:23-cv-00106-TSK-JPM) MOTION for Guidance Regarding Temporary Restraining Orders in View of the May 18, 2024 Expiration of Regulatory Exclusivity for Eylea filed by Samsung Bioepis Co., Ltd.. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/05/2024) (7) |
| May 3, 2024 | 35 | Filing fee: $ 800.00, receipt number 100003889. (For Attorneys B. Postal, J. Nock, E. Figg and J. Hynds) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) Modified docket text on 5/3/2024 (snc). (Entered: 05/03/2024) (0) |
| May 3, 2024 | 36 | MOTION for Guidance Regarding Temporary Restraining Orders in View of the May 18, 2024 Expiration of Regulatory Exclusivity for Eylea by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/03/2024) (6) |
| May 3, 2024 | 37 | Filing fee: $ 600.00, receipt number 100003890 (For Attorneys E. Agovino, P. Pelletier and A. Whiteford) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/03/2024) (0) |
| May 2, 2024 | 33 | Filing fee: $ 600.00, receipt number 100003887. (For Attorneys K. Flowers, T. Burns and J. Labbe) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(snc) (Entered: 05/02/2024) (0) |
| May 2, 2024 | 34 | Amgen's Withdrawal of Its Motion Requesting an Expedited Status Conference Other Document filed by Amgen, Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/02/2024) (3) |
| Apr 30, 2024 | 31 | ORDER GRANTING 27 MOTION FOR LEAVE TO FILE UNDER SEAL. Signed by Chief District Judge Thomas S. Kleeh on 04/30/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00089-TSK-JPM (snc) (Entered: 04/30/2024) (1) |
| Apr 30, 2024 | 32 | ORDER 29 GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL. Signed by Chief District Judge Thomas S. Kleeh on 04/30/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 04/30/2024) (2) |
| Apr 29, 2024 | 25 | ***SEALED*** ORDER ADDRESSING PENDING MOTION TO SEAL (ECF NO. 200) Signed by Chief District Judge Thomas S Kleeh on 04/29/2024. (Copy emailed to counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM(snc) (Entered: 04/29/2024) (0) |
| Apr 29, 2024 | 26 | ***SEALED***ORDER ADDRESSING PENDING MOTION TO SEAL (ECF NO. 182). Signed by Chief District Judge Thomas S. Kleeh on 04/29/2024. (Copy emailed to counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00106-TSK-JPM(snc) (Entered: 04/29/2024) (0) |
| Apr 29, 2024 | 27 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) () (4) |
| Apr 29, 2024 | 29 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) () (5) |
| Apr 29, 2024 | 27 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) (Attachment Memorandum in Support) (6) |
| Apr 29, 2024 | 27 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) (Proposed Order) (1) |
| Apr 29, 2024 | 29 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) (Attachment Memorandum in Support) (7) |
| Apr 29, 2024 | 29 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) (Proposed Order) (2) |
| Apr 26, 2024 | 23 | ORDER CANCELING STATUS CONFERENCES. On April 11, 2024, each of the cases became member cases of the MDL Case No. 1:24-md-3013. For that reason, the status conferences are CANCELED. Signed by Chief District Judge Thomas S. Kleeh on 4/26/2024. Associated Cases: 1:24-md-03103-TSK et al. (jb) (Entered: 04/26/2024) (1) |
| Apr 26, 2024 | 24 | PRETRIAL ORDER #1: INITIAL SCHEDULING CONFERENCE. Scheduling Conference is set for 5/17/2024 11:00 AM by Zoom Videoconference before Chief District Judge Thomas S. Kleeh. Signed by Chief District Judge Thomas S. Kleeh on 4/26/2024. Associated Cases: 1:24-md-03103-TSK et al. (jb) (Entered: 04/26/2024) (10) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) () (2) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Attachment Memo ISO) (22) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 1) (2) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 2) (30) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 3) (8) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 4) (11) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 5) (5) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 6) (5) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 7) (1) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 8) (1) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 9) (1) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 10) (7) |
| Apr 25, 2024 | 21 | MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Proposed Order) (3) |
| Apr 24, 2024 | 10 | ORDER GRANTING AMGEN INC.S MOTION FOR LEAVE TO FILE ITS MOTION REQUESTING AN EXPEDITED STATUS CONFERENCE UNDER SEAL. Amgen shall promptly file its Motion for Leave to File Its Motion Requesting an Expedited Status Conference under seal. Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (dk) (Entered: 04/24/2024) (1) |
| Apr 24, 2024 | 11 | ***SEALED*** ORDER ADDRESSING PENDING MOTION TO SEAL (ECF NOS. 8 , 207 ). Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. (Emailed to Counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00097-TSK-JPM (dk) (Entered: 04/24/2024) (0) |
| Apr 24, 2024 | 13 | ORDER CONTINUING MAY 2, 2024 PERMANENT AND PRELIMINARY INJUNCTION HEARINGS. The Court will reschedule the preliminary and permanent injunction hearings, if necessary, by separate order. For reasons stated herein, the parties' Joint Motion for Status Conference Regarding the May 2, 2024 Permanent and Preliminary Injunction Hearings is also DENIED (ECF No. 9 ). Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. Associated Cases: 1:24-md-03103-TSK et al. (dk) (Entered: 04/24/2024) (2) |
| Apr 24, 2024 | 14 | ***SEALED*** ORDER ADDRESSING PENDING MOTIONS TO SEAL (ECF NOS. 157 , 160 ). Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. (Emailed to Counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00089-TSK-JPM (dk) (Entered: 04/24/2024) (0) |
| Apr 24, 2024 | 15 | ***SEALED*** ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 747 . Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. (Copy to Counsel) Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM (dk) (Entered: 04/24/2024) (0) |
| Apr 24, 2024 | 17 | ***SEALED*** ORDER ADDRESSING PENDING MOTIONS TO SEAL (ECF NOS. 194 , 195 ). Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. (Copy to Counsel)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM (dk) (Entered: 04/24/2024) (0) |
| Apr 24, 2024 | 18 | ***SEALED*** ORDER ADDRESSING PENDING MOTIONS TO SEAL (ECF NOS. 176 , 177 ). Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. (Emailed to Counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00106-TSK-JPM (dk) (Entered: 04/24/2024) (0) |
| Apr 24, 2024 | 19 | ORDER GRANTING DEFENDANT'S MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NOS. 153 , 172 ). The Clerk is DIRECTED to convert each motion to seal into the pleading that is attached. Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM (dk) (Entered: 04/24/2024) (1) |
| Apr 23, 2024 | 9 | Joint MOTION for Status Conference Regarding the May 2, 2024 Permanent and Preliminary Injunction Hearings by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 04/23/2024) (9) |
| Apr 19, 2024 | 7 | NOTICE of Appearance by Kaitlyn N. McKitrick on behalf of Amgen, Inc., Amgen, Inc. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(McKitrick, Kaitlyn) (Entered: 04/19/2024) (1) |
| Apr 18, 2024 | 5 | NOTICE of Appearance by Ashley Hardesty Odell on behalf of Amgen, Inc., Amgen, Inc. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/18/2024) (1) |
| Apr 17, 2024 | 3 | MEMBER CASE OPENED: Case Transferred into the Northern District of West Virginia: California Central District, 2:24-cv-264, Regeneron Pharmaceuticals, Inc. v. Amgen, Inc., as NDWV Case No. 1:24-cv-39 pursuant to 1 JPML Transfer Order. (kac) (Entered: 04/17/2024) (0) |
| Apr 17, 2024 | 4 | Defendant Formycon AG's Reply in Support of Its Objections to Magistrate Judge Mazzone's Sealed Order Denying Its Emergency Motion to Compel Other Document re (179 in 1:23-cv-00097-TSK-JPM) Objections, (142 in 1:23-cv-00097-TSK-JPM, 142 in 1:23-cv-00097-TSK-JPM) Order on Motion to Compel, Sealed filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 04/17/2024) (5) |
| Apr 12, 2024 | 2 | MEMBER CASES OPENED: Cases directly Filed in the Northern District of West Virginia: Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals, Inc., NDWV Case 1:22-cv-61, Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., NDWV Case No. 1:23-cv-89, Regeneron Pharmaceuticals, Inc. v. Samsun Bioepis, Co., Ltd., NDWV Case No. 1:23-cv-94, Regeneron Pharmaceuticals, Inc. v. Formycon AG, NDWV Case No. 1:23-cv-97, and Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd., NDWV Case No. 1:23-cv-106. All cases are incorporated into this MDL pursuant to MDL No: 3103 1 Transfer Order. (kac) (Entered: 04/15/2024) (0) |
| Apr 11, 2024 | 1 | JPML TRANSFER ORDER re: MDL No. 3103 Transferring 1 action to Judge Thomas S. Kleeh in the N.D. West Virginia. Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 4/11/2024. Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106. (kac) (Entered: 04/15/2024) (5) |
